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Severe mental illness in adults refers to a group of mental health conditions including 
schizophrenia and schizoaffective, bipolar and major depressive disorders. These conditions are 
often characterized by recurring symptoms, multiple hospitalizations, and significant disability. 
The public health concern with these conditions is amplified because many individuals with 
severe mental illness fail to engage in outpatient treatment. Methods to support greater rates of 
participation in outpatient treatment are needed. Encouraging participation in medical decision-
making is viewed as one method to optimize patient empowerment, increase engagement in care 
and decrease the negative outcomes that often characterize this population. Shared Decision 
Making (SDM) is a collaborative and structured approach to patient-provider communication 
viewed as a negotiation between mutual experts with the goal of balancing empirical information 
with patient values and preferences.  
 
This was a cross-sectional mixed methods study examining SDM in a sample of 
individuals with severe mental illness who have recently been discharged from emergency rooms 
and inpatient psychiatric facilities. Extant data on decision-making preferences and a variety of 
 
 
clinical, demographic and communication variables were analyzed on 258 individuals with 
severe mental illness during a baseline visit at a transitional care clinic serving individuals 
immediately after hospital discharge. The association between clinical, demographic and 
communication characteristics and patients’ self-reported decision-making preference (active, 
collaborative, or passive) were examined using chi square and one-way analyses of covariance. 
In addition, we conducted semi-structured qualitative interviews with 15 individuals with serious 
mental illness a variety of clinical providers (n = 9).   
 
Results from the quantitative analyses indicated that race/ethnicity was significantly 
associated with the SDM preference group, with African American individuals desiring more 
active participation in decision making compared to their Hispanic counterparts. Other 
characteristics were not significantly associated with the patient’s baseline decision-making 
preferences in this context. Qualitative data were analyzed using latent thematic analysis and six 
themes were identified including: 1) Differences in the Use of SDM, 2) Consideration of Past 
Experiences, 3) Decisional Power Preferences, 4) Use of SDM in Psychiatry Versus Other Areas 
of Medicine, 5) Dignity and Disengagement, and 6) External Forces Impacting SDM. These 
findings indicate race/ethnicity may be an important factor when using a SDM approach. 
Implications for clinical practice and research using a SDM approach within this treatment 
setting are further discussed.   
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BACKGROUND 
 
Engagement in mental health services following hospitalization is of critical importance 
for improving the lives of individuals with severe mental illness and reducing long term 
disability.  In this manuscript, we describe the personal and societal costs of severe mental 
illness, models of care for this population, the importance of shared decision making in the 
treatment-engagement process, and the barriers and facilitators of shared decision making.  Next, 
we propose a research project designed to better understand patient preferences for different 
types of decision making during encounters with prescribers and elucidate the process of shared 
decision making and treatment from the patient and prescriber-staff perspectives.   
 
Severe mental illness in adults refers to a group of mental health disorders often defined 
by length of illness duration and the disability it produces. These illnesses include disorders that 
produce psychotic symptoms, such as schizophrenia and schizoaffective disorder, and severe 
forms of affective disorders, such as major depression and bipolar disorder (SAMHSA, 2016). It 
is estimated that 4.6% percent of the adult US population is diagnosed with one of these 
conditions at any given time (NIMH, 2016). Serious mental illness is one of the leading causes of 
disability worldwide according to the global burden of disease disability weights (Kessler et al, 
2009; WHO, 2006). The course of this group of disorders is often characterized by recurring 
exacerbations and multiple hospitalizations (Moller, 1995). Additionally, recent literature reports 
people with serious mental illness die 10-20 years earlier than do those not suffering from this 
group of diseases (University of Oxford, 2014; Lund University, 2013); much of the excess 
mortality being due to physical illness.  The comorbidity of medical illness in this population is 
well documented, including particularly elevated rates of diabetes mellitus (2-3 fold), metabolic 
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syndrome (1.5-2 fold), cardiovascular disease (2-3 fold) and viral diseases (5-11 fold), when 
compared to the general population (DeHert et al, 2011; Sokol et al, 2004).  
 
The per patient lifetime burden of serious mental illness is estimated at $1.85 million 
(Seabury et al, 2019). Services with the highest costs include hospitalization and emergency 
department visits. In an extensive review of psychiatric admissions to 418 U.S. community-
based hospitals, it was determined that the three most common diagnoses included depression 
(27.8%), schizophrenia/schizoaffective disorder (19.5%) and bipolar disorder (19.4%; Stensland 
et al, 2012). These diagnoses are included in the broader category of serious mental illness. 
Typical psychiatric hospitalizations for the severely mentally ill last only a few days (x̅ = 4.4 – 
11.1; Stensland et al, 2012), leaving many individuals still experiencing severe psychiatric 
symptoms at the time of discharge. The recurring hospitalization and emergency care utilization 
as part of ongoing serious mental illness management coupled with an over-burdened outpatient 
mental health service care system (Mead, 2002) result in as many as one-half of these individuals 
failing to connect to sustained outpatient care (Boyer, 1997). This places patients at greater risk 
of numerous negative outcomes, including repeated emergency department visits and inpatient 
hospitalizations, homelessness, violence against others and suicide (Dixon et al, 2009; Fisher et 
al, 2008). According to Pasic and colleagues (2005), high utilization of hospital and emergency 
services points to a quality of care and access problems in outpatient care that must be addressed. 
To this effect, it has been suggested that these negative outcomes may decrease within the mental 
health population if patients have more involvement in psychiatric decision making (Kemp, 
2011). Correspondingly, engagement in outpatient services may be enhanced with a higher level 
of patient empowerment within the patient-physician dyad (McCallister, 2016).  
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Poor long-term engagement in outpatient treatment contributes to psychiatric re-
hospitalization and more frequent emergency department visits (Pasic et al, 2005). There is 
substantial evidence that psychiatry patients miss approximately 20% of ongoing treatment 
appointments, and nearly half of patients who miss an appointment drop out of care, leading to 
premature discontinuation rates in psychosocial treatment, as high as 82% (McMurran, 2010; 
Mitchell, 2007; Wierzbicki, 1993). Specific to hospitalization data, Prince (2006) reports that 
patients who are not engaged in care (i.e. medication appointments) within three months of 
hospital or emergency department discharge, experience significantly higher re-hospitalization 
rates than patients who do participate in aftercare treatment (OR=6.9, p<0.001). Moreover, 
medication non-adherence rates often exceed 50% in psychiatric samples (Velligan et al, 2006), 
with ethnic minorities and younger adults consistently less likely to take medications as 
prescribed (Rossom et al, 2016; Garcia et al, 2016; Lee et al, 2008). 
 
The importance of treatment engagement and continuity of care between inpatient or 
emergency room facilities and outpatient services to prevent this revolving door phenomenon has 
been continually stressed (Mental Health America, 2010). Even minimal contact with aftercare 
treatment is associated with lower recidivism rates (Silva, 2009); conversely, delays seeking 
outpatient care following psychiatric hospitalization are linked to poorer outcomes (Prince 2006; 
Weiden, 2004). Based on these studies, the months immediately post-discharge appear critically 
important for implementing strategies to improve engagement in outpatient treatment. However, 
research on the best way to increase post-acute psychiatric patients’ long-term engagement with 
mental health services is mixed and provides no clear direction for treatment improvement. 
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There is some suggestion from recent published literature on the general population that 
long-term engagement into outpatient treatment may be assisted by empowerment of the patient 
in decisions about their care within the patient-provider dyad (McCallister, 2016). Within the 
seriously mentally ill population specifically, various intervention approaches have been used to 
increase follow-through adherence to outpatient treatment (Roberts, 2011), but most methods do 
not emphasize the importance of patients participating in their own treatment decisions. Shared 
Decision making (SDM) is an exception. SDM is a structured approach to patient-provider 
communication in medicine that frames the interaction as a negotiation between mutual experts 
and stresses the balanced use of empirical information and patient preference in decision making 
(Charles, 1997).  
 
There are few published large-scale studies of SDM in persons with serious mental 
illness. This lack of information results in a knowledge gap in several areas. Two of these gaps 
are addressed in this proposal. 
 
1) There is little research examining how patient preferences for involvement in the 
process of treatment decisions with a prescriber relate to clinical and demographic 
characteristics. Furthermore, there is no published literature addressing how patients’ clinical and 
demographic characteristics relate to their perceptions of the decision-making encounter.  In 
addition, it is unclear how these clinical and demographic characteristics relate to discrepancies 
in how patients and prescribers view the encounter.   
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2) There is no published information regarding the feasibility of using an SDM approach 
in a post-acute psychiatric clinic. The perspectives of both patients receiving SDM and 
prescribers/staff functioning within this context have not been researched.  These questions may 
be best addressed using in-depth interviews with those participating in the provider–patient 
interactions.  
 
The specific aims of this study address these gaps and are listed below.   
 
Specific Aims 
Aim #1: Characterize the demographic and clinical differences between groups of patients 
who desire differing levels of involvement in psychiatric decision making.  
Use pre-existing data on 258 individuals with serious mental illness to characterize patient 
preferences for types of decision making using the Control Preference Scale into three groups 
(Active/Collaborative/Passive). Examine group differences on patient demographic and clinical 
variables, how patients view the initial encounter with prescribers, and the extent to which their 
view of the encounter differs from that of the prescriber.  
 
Aim #2: Identify the factors influencing the use of a shared decision-making model in post 
psychiatric crisis care delivery.   
Assess individual experiences with the shared decision-making model, barriers and facilitators of 
the approach, and the feasibility of using the model for care delivery from the perspective of 
prescribers, clinic administrators, therapists nursing staff and patients. This is accomplished via 
one-on-one interviews with fifteen patients, four prescribers, two therapists, one nurse and two 
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clinic administrators.  
 
Literature Review 
 
Post Hospital Engagement in Care 
 
There are several models of post-hospitalization care presented in the literature. Dixon 
and colleagues (2009) use a brief intervention implemented for individuals with serious mental 
illness at time of hospital discharge focusing on assessing barriers to treatment and facilitating 
engagement in community-based services. This three month intervention increased show rates to 
outpatient medication appointments, although no effect was found on rehospitalization.  In an 
older sample of 59 psychiatric inpatients, Kopelowicz (1998) found that patients with 
schizophrenia who participated in a re-entry program for one month post-discharge were 
significantly more likely to attend their first aftercare appointment. While one study associated 
the use of day treatment for individuals with schizophrenia with a significant reduction in future 
admissions (Kopelowicz, 1998), a review article of four randomized trials concluded there is 
insufficient evidence to deem such intense treatment effective within this population (Shek, 
2010). Additionally, in a study on the use of medication management coordinators providing 
continuity of care procedures between inpatient and outpatient care for persons diagnosed with 
severe mental illness, survival curve analyses reveal those in active treatment attended outpatient 
appointments sooner in comparison to the control group, but no difference was found in time to 
next psychiatric hospitalization (Maples, 2012). These studies suggest there is no clearly 
effective strategy leading to improved engagement in outpatient treatment after hospitalization or 
to improved outcomes, indicating other options need to be investigated. Next, several models are 
explored to provide a foundation for potential intervention strategies.  
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Chronic Care Models and Framework 
 
Drawing from the public health literature, we examined multiple models describing the 
management and delivery of chronic care. Models selected were based on the following 
parameters: 1) The relationship of the model to chronic relapsing conditions involving high 
service use and high cost, 2) The inclusion in the model of optimization of patient self-direction 
and outcomes and 3) The inclusion of a component of training and competency for the 
professional staff providing care. We excluded models (ecological, social-ecological and 
exposome) not addressing breaking the repeated cycle of rehospitalization often experienced in 
this group of illnesses and those without a focus on enhancing empowerment of the individual in 
treatment.  The three models discussed in this proposal include, Wagner’s Chronic Care Model, 
the Institute for Healthcare Improvement Triple Aim Framework and Mulley’s Conceptual 
Framework for Shared Decision making. These models have primarily been discussed with 
respect to physical illness but remain relevant to severe and persistent mental health disorders as 
explained below. 
 
Wagner’s Chronic Care Model 
In a review article by Wagner et al (1996), the authors stress the need for integrated, 
patient-centered care for chronic illness. Wagner’s model (Figure 1) emphasizes that patients be 
actively involved in their own care, and also emphasizes practice redesign, ongoing education for 
providers, and meaningful use of information systems (Wagner et al, 1999). This transformative 
model of health care delivery addresses how to overcome the following deficiencies: 
practitioners being rushed, a lack of care coordination, the lack of active follow-up, and patients 
being inadequately trained to manage their illness (Wagner et al, 1996). As seen in Figure 1, 
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changes in both the community and in the health system itself can lead to a more informed and 
activated patient, in addition to a more prepared and proactive practice team--with improved 
outcomes being the primary goal. As seen in the model, changes within the community and the 
health system that promote access, communication across agencies and patient education must 
occur together to reach the overall goal of improved patient outcomes. While Wagner’s model 
pertains to the health industry in general, these same principles may apply to the treatment 
settings of individuals with serious mental illness. Given the information previously presented on 
comorbidity between serious mental illness and physical health diagnoses—including the 
increased morbidity and mortality rates—the application for more integrated care, the redesign of 
practice, and meaningful use of information systems is necessitated in treating this chronically ill 
population.  
Figure 1. Wagner’s Chronic Care Model 
 
Source: Wagner EH, 1998 
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Institute for Healthcare Improvement Triple Aim Framework 
 The Institute for Healthcare Improvement’s (IHI) Triple Aim is a framework describing 
an approach to optimizing health system performance. The Triple Aim consists of: 1) Improving 
the patient experience of care (including quality and satisfaction), 2) Improving the health 
of populations; and 3) Reducing the per capita cost of health care (Berwick et al, 2008). These 
three aims can be seen in Figure 2, a simple yet notable plea for designing healthcare systems. A 
shared decision-making approach within the seriously mentally ill population is relevant to all 
three of the Aims outlined in the model.  Shared decision making has been found to improve the 
patient’s experience of care by encouraging providers to present more treatment options and 
involving patients to a greater extent in decsions.  This can have an important impact on  early 
engagement  in treatment and promoting satisfaction with care.  This may help to increase 
appointment adherence which is often a problem in providing services for this population. 
Expediting indivdiuals into care immedately following an acute psychiatric exacerbation and 
engaging them in the decision making process is likely to improve health outcomes and reduce 
healthcare costs.  Most importantly, this framework calls for efforts to improve care and close 
the treatment gap for individuals with serious mental illness across a variety of settings; an 
unified behavioral health strategy which includes the patient in helping direct their own care is 
essential to achieve the Triple Aim.    
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Figure 2. The Institute of Healthcare Improvement’s Triple Aim 
  
Source: Institute for Healthcare Improvement, 2020 
 
Mulley’s Conceptual Framework for Shared Decision Making 
The concept of shared decision making is previously and briefly mentioned in this 
dissertation proposal. The model presented here (Figure 3) is the original published by Mulley 
(1990) with a target audience of primary medicine. As described by Mulley (1990), SDM is a 
systems approach to enable continuous improvement in clinical decision making. The model 
focuses on two key participants, the patient and provider. There is a fundamental social nature in 
the decision-making task that cannot be completed by the doctor or patient alone, but rather 
requires productive interactions (and communication) between them. The model focuses on three 
types of events. First, decisions – the selection of treatment based on patients’ well-informed 
preferences for health outcomes. Second, clinical practice – where the treatment is implemented. 
Third, health outcomes – the expected result of treatments. The model includes two major 
feedback loops to indicate how learning occurs in the system. The top loop feeds knowledge 
about the likelihood of outcomes to providers to promote evidence-based medicine. The bottom 
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loop feeds knowledge about the patient’s subjective assessment of experiences with those 
outcomes back to the point of decision making to support more informed choices.   
 
In this shared decision-making model, prescribers are primarily responsible for knowing 
and appropriately applying the knowledge base. Patients are primarily responsible for 
contributing well-informed subjective assessments of possible health states relevant to decisions 
and for reporting outcomes and experiences with and assessment of these health states. The 
responsibility on key participants is high, but also at the center of success in such a model. The 
complexity and responsibilities required raise questions as to appropriateness for application 
within a post-acute psychiatric population. However, the three concepts postulated – decisions, 
clinical practice and health outcomes, certainly remain relevant whether in a mental or physical 
health population. Additionally, current clinical practice guidelines advocate for all clinicians, 
regardless of public health sector, to involve clients in decision making processes and allow for 
client preferences, along with the evidence, to guide decisions where possible. This model 
provides the opportunity to optimize patient self-direction in mental health treatment and 
outcomes. 
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Figure 3. Mulley’s Conceptual Framework for Shared Decision Making 
Source: Sepucha and Mulley, 2009 
 
In conclusion, the frameworks presented in this literature review are all consistent with 
the mission of The Center for Medicare and Medicaid Innovation for improved care delivery 
systems, as part of the Affordable Care Act (Shrank, 2013; Barr et al, 2010). However, they 
simultaneously raise questions on applicability and achievability of several synchronous complex 
processes needed to achieve better outcomes for patients. Next, a body of literature is presented 
on shared decision making, the principal subject for the remainder of this proposal. 
 
Shared Decision Making 
 
Research suggests that long term engagement into outpatient treatment may be assisted 
by empowerment of the patient in decisions about their care within the patient-provider dyad. 
Patients who feel they are playing an active role in their treatment typically have better 
13 
 
engagement and outcomes than patients who experience themselves as passive recipients of care 
(Greenfield, 1988; Seeman 1983; Stewart 2001). Unfortunately, across diagnoses and conditions, 
patients more typically engage with providers in a passive manner (Britten, 2000; Towle, 2003), 
and lack of engagement is related to poor adherence with prescribed regimens. Poor adherence 
has severe consequences for individuals immediately following hospitalization or crisis care, 
often leading to recidivism and decreased quality of life (Velligan, 2009).  
 
Although various intervention approaches have been used to increase follow-through 
adherence to outpatient treatment in serious mental illness (Roberts, 2011), most methods do not 
emphasize the importance of patients participating in their own treatment decisions. Shared 
Decision making is an exception. SDM is a structured approach to communication in medicine 
that frames the interaction as a negotiation between mutual experts (patient and provider) and 
stresses the balanced use of empirical information and patient preference in decision making 
(Charles, 1997). Within the physical medicine field, there is substantial evidence that SDM 
increases patient participation in and adherence to treatment and may decrease adverse events 
and unnecessary procedures (Dowell, 2007; Stewart, 1995; Wennberg, 2007). SDM also appears 
to increase patients’ knowledge about and realistic understanding of the targeted illness 
(Auerbach, 2001). SDM is compatible with evidence-based medicine in its emphasis on the use 
of empirical information to make treatment decisions (Guyatt, 2001), and with the serious mental 
illness consumer recovery movement in its emphasis on patient-centered care (Drake, 2010).  
  
SDM is well operationalized, with specific components and clinician competencies detailed in 
the literature (Campbell, 2007; Elwyn, 2005). SDM coaching is an approach where clinical staff, 
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following standard SDM concepts, help empower patients with the goal to enhance patient 
communication skills, knowledge and options for communication with their prescribers. 
Coaching visits occur prior to the medication appointment and are one-on-one meetings that 
address patients’ treatment and diagnosis questions, informational needs, goals, medication 
concerns and strategies for communication. In light of the research on chronic care presented 
above, SDM may be effective with chronic conditions, such as psychiatric illness, because the 
focus of SDM is to help the individual be a more educated and involved consumer of health 
services, with the inherent opportunity to direct more of their own care. 
 
Barriers to SDM Implementation with Serious Mental Illness 
 
Despite the apparent promise of SDM, there is a low level of adoption and 
implementation of this practice within the delivery of mental health care, relative to other areas 
of medicine.  The delivery of mental health services remains for the most part a provider-
dominated decision-making climate, reflecting poor uptake of this practice (Curtis, 2010; 
Shumway, 2003). Possible reasons for the insufficient adoption of SDM within this population 
are further explained. Table 1 summarizes barriers to SDM implementation and dissemination in 
the seriously mentally ill population. These factors are further illuminated below.  
 
Table 1. Summary of Potential Barriers to SDM Implementation in Seriously Mentally Ill 
Population  
 
Summary of Potential Barriers to SDM Implementation in Seriously Mentally Ill 
Population 
Prescriber/Systemic Factors • Overworked physicians 
  • Insufficient provider training/knowledge in SDM 
  • Deficient medical information systems 
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  • Physician time constraints 
  • Lack of applicability to population 
  • Inappropriate clinical situation (i.e. crisis clinic) 
Patient Factors 
• Mixed opinions on amount of involvement in 
decision process 
  
• Patient perceptions of clinician failures at using 
SDM 
  
• Inability of patient to accurately articulate 
information (Possible need for decision support 
aids) 
Illness/Symptom Factors • SDM participation requires higher cognitive load 
  
• Persons with serious mental illness may suffer 
from cognitive impairment or judgment 
difficulties 
  • Depression makes decision making more difficult 
  • Mania may lower the threshold for risk tolerance 
  
• Schizophrenia may lead to passive acceptance 
(i.e. apathy) or rigid non-compliance (i.e. 
paranoid delusion) 
 
Prescriber/Systemic Factors 
 It is difficult to separate prescriber and systemic barriers to SDM implementation as 
they appear to be integrally intertwined. Efforts to increase patient involvement in decisions 
about their care face barriers such as overworked physicians, insufficient provider training, 
deficient medical information systems, physician time constraints, a deemed lack of applicability 
due to patient characteristics and inappropriate clinical situations (Legare, 2008; Towle, 2006). 
From the standpoint of efficiency, when SDM is used in prescriber-patient interactions, visits are 
perceived by prescribers to take more time than does a standard psychiatry appointment (Burton, 
2010)—and doctors cite this as one factor that limits their use of SDM (Legare, 2008; Towle, 
2006). While the need for SDM content varies in each prescriber-patient appointment (i.e. patient 
experiencing side effects or is decompensating versus no complaints), all prescriber-patient 
interactions should include some component of SDM when following the model correctly. As 
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physicians use SDM only about 10% of the time (Braddock, 1997; Elwyn, 2003), efficiency 
appears to be an important perceived obstacle to the feasibility and dissemination of SDM.  
 
Despite a desire to know more about their diagnosis, treatment options and side effects 
(Beisecker, 1990; Degner, 1997), psychiatric patients report that prescribers often do not provide 
sufficient information or explain it in an understandable manner (Garfield, 2004). A large 
interview-based study on perceived obstacles and needs in providing SDM in public mental 
health corroborated this patient perspective, concluding that mental health providers require 
additional training in effective patient communication—above and beyond the kind of training 
they receive for other chronic and acute physical health conditions (Mahone, 2011). 
 
Patient Factors 
There are mixed reviews on patients’ desires for more information on care options and 
amount of involvement in the medical decision-making process (Legare, 2008, Legare, 2006). 
During a baseline office interview in the general (non-psychiatric) population, one study found 
25% of patients want an active role where they are primarily responsible for the decision, 53% 
want a collaborative role and 21% want a passive role that gives the prescriber more power in the 
decision making process. Additionally, Mahone (2011) suggests that in addition to the need for 
more provider training, patients’ perceptions of clinician failures at using SDM may be due in 
part to illness-related information processing deficits in the patient, recommending increased 
training for patients in articulating their expert information during treatment sessions. To aid in 
information exchange and knowledge building, reviews of SDM in mental health have called for 
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the use of decision support aids and other scaffolding techniques to support patient preferences in 
decisions about their care (Deegan, 2006).  
 
Illness/Symptom Factors 
In addition to prescriber, systemic and patient factors, symptoms that typically 
accompany serious mental illness cause concerns about patients’ abilities to fully participate in 
SDM. SDM requires a certain amount of cognitive capacity to understand treatment options and 
weigh their pros and cons against one’s own preferences. Many individuals with serious mental 
illness suffer from cognitive impairments that may hinder their ability to complete this complex 
cognitive processing. Further, some psychiatric conditions specifically affect judgment and 
decision making, calling into question the decisional capacity of psychiatric patients to make 
informed decisions about their care (Appelbaum, 2006; Hamann, 2003). Additionally, depression 
makes decision making more difficult; mania may lower the threshold for risk tolerance; 
schizophrenia may alternately lead to passive acceptance or to rigid adherence to one idea 
(Moritz, 2006), such as a paranoid fear regarding medication.  
 
Strengths of SDM Implementation in Serious Mental Illness 
 
While there are obvious barriers to SDM implementation, SDM has many strengths and 
evidence supports the use such an approach for those with serious mental illness. Table 2 
summarizes these strengths and the information is expanded on below.  
Table 2. Summary of Strengths to SDM Implementation in Seriously Mentally Ill 
Population 
Summary of Strengths to SDM Implementation in Seriously Mentally Ill Population 
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Prescriber/Systemic Factors 
• Support through the New Freedom Commission 
on Mental Health and other government policy 
reports 
  
• High incidence of patient non-adherence, 
partially due to dissatisfaction 
  
• For rational/purposeful medication non-
compliance, SDM may constitute a reasonable 
approach to remaining engaged in care while 
continually re-evaluating the potential role of 
medication 
  
• SDM represents a non-threatening approach for 
prescribers to clarify motivation 
Patient Factors 
• Reports reveal nearly 90% of patients want 
information on diagnosis, treatment options and 
side effects 
  
• Specific demographic factors may contribute to 
patients' preference to play a more active role in 
decision making 
  
• Patient experience and knowledge of illness, type 
of decision needed and attitude towards 
involvement affect desire to be active in decisions 
and care 
Illness/Symptom Factors 
• Evidence that persons with serious mental illness 
frequently make competent and prudent treatment 
decisions 
  
• Medication taking is often part of a deliberate 
self-care plan 
  
• Persons with serious mental illness express a 
strong desire to be informed about illness and 
treatment options 
 
Systemic Factors 
Research on SDM in psychiatry has received support through the New Freedom 
Commission on Mental Health (New Freedom Commission, 2003), and other recent government 
policy reports (Institute in Medicine, 2001; IoM, 2005). SDM may be of particular benefit in 
serious mental illness because of the high incidence of patient non-adherence with treatment due 
to factors including dissatisfaction with side effects from antipsychotic and mood stabilizing 
medications, poor insight into illness and functional and motivational impairments. Competent 
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adults with serious mental illness sometimes choose to decline medication and suffer symptoms 
rather than endure side effects, or to limit their use to periods of symptom exacerbation 
(Donovan, 1992; Angermeyer, 2001). For these patients, SDM may constitute a reasonable 
approach to remaining engaged with care providers and take advantage of treatment options such 
as case management and/or alternative medications and psychotherapy, while continually re-
evaluating the potential role of antipsychotic medication. For patients with poor insight or 
functional impairment, SDM represents a non-threatening approach to clarifying motivations and 
options for improving quality of life. 
 
Patient Factors 
In surveys, nearly 90% of patients in the general population want information on their 
diagnosis, treatment options and side effects (Beisecker, 1990; Degner, 1997). However, it is 
unknown whether this preference translates to those with severe mental illness, especially to 
those experiencing an acute psychiatric exacerbation. In a 2006 review of patients’ preferences 
for involvement in decision making, Say et al (2006) report demographic variables, including 
being younger, better educated and female were consistently found to be associated with a 
preference for a more active role in decision making. The authors add that patient experience of 
illness, the type of decision they need to make, the amount of knowledge they have acquired 
about their illness and their attitude towards involvement, also affect desire to be involved in 
care.  
 
Illness/Symptom Factors 
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Contradicting the risks related to symptomatology, there is evidence that adults with 
serious mental illness frequently make competent and prudent treatment decisions (Grisso, 1995; 
MacDonald et al, 2017). For example, a study of medication decision making in schizophrenia 
found that nearly 87% of patients prescribed injectable (depot) antipsychotics chose to continue 
(Bunn, 1997). In a large study of patient self-care in serious mental illness, when patients made 
firm decisions about whether or not to take medication they typically did so as part of a 
deliberate self-care plan. Also, despite frequent behavioral passivity, patients with serious mental 
illness express a strong desire to be informed about their illness and treatment options, and to be 
active participants in their treatment decisions (Adams, 2007; Arora, 2000; De las Cuevas, 
2001). 
 
Feasibility 
 
While few large-scale studies exist on the use of SDM within the seriously mentally ill 
population, at least two studies demonstrate promise.  A trial that provided a medication decision 
aid and coaching for communication with doctors to inpatients diagnosed with schizophrenia 
(N=107) found that the intervention was feasible and well tolerated by patients and was 
associated with a trend toward decreased rehospitalization (Deegan, 2006). A second inpatient 
trial (Hamman, 2011) randomized patients with schizophrenia or schizoaffective disorder to 
either an SDM intervention (N=32) or cognitive training (N=29). The SDM intervention 
comprised five sessions addressing motivation for decision making participation and role-play 
practice to improve communication skill. SDM was found to be feasible and was associated with 
increased desire for participation in treatment decisions relative to cognitive training, a finding 
that remained at six-month follow-up.  
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In summary, there is a body of evidence in the published literature on shared decision 
making. Despite promising data on the use of SDM, the uptake of this practice is poor within 
services provided to the seriously mentally ill population. A better understanding of the factors 
related to shared decision-making styles in different patients and issues related to its 
implementation may be critical to maximizing individual patient outcomes.  Currently, there is 
insufficient evidence on how much involvement severely ill psychiatric patients desire to have in 
their patient-provider interactions regarding psychiatric decisions. While previous studies have 
found factors such as age and gender to impact the desired level of involvement in care, it is 
unclear if these results translate to the population of individuals with severe mental illness.  
Moreover, there is no evidence to date on how factors such as the level of psychiatric 
symptomatology, level of insight and ethnicity are related to patient’s desire to participate in 
treatment. Furthermore, little is known about the opinions of those engaging in SDM within a 
post-acute psychiatric clinic and how these beliefs by patients or providers may hinder or 
facilitate the uptake of SDM within this population. This lack of information results in a gap in 
the current knowledge base on the viability of SDM usage within this population and a post-
acute psychiatric clinic. 
Public Health Significance 
 
Specific to mental health, The President’s New Freedom Commission (PNFC) on Mental 
Health identified patient-directed care as one method of service delivery that could improve the 
quality and outcomes of mental health (PNFC, 2003). The Commission called for nothing short 
of fundamental transformation of the mental health care delivery system in the United States, 
from one dictated by bureaucratic and financial incentives to one driven by consumer and family 
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needs that focuses on building resilience and facilitating recovery. In its October 29, 2002, 
Interim Report to the President, the Commission declared that the mental health service delivery 
system must be robust and responsive to consumers' needs because its failings may lead to 
"unnecessary and costly disability, homelessness, school failure and incarceration." The report 
points out that mental illnesses and emotional disturbances are treatable, and that recovery 
should be the expectation. Successfully transforming the mental health service delivery system to 
promote recovery hinges on treatments that are consumer driven. Finally, the report underscores 
the importance of giving consumers real and meaningful choices about treatment options.  
 
Based on the body of research presented throughout, methods of increasing patient 
engagement that incorporate treatments driven by the consumer are of national public health 
significance.  A myriad of poor patient outcomes coupled with high financial costs for those 
diagnosed with serious mental illness promote research on the barriers, facilitators and feasibility 
of novel interventions in this population, including patient-level factors surrounding treatment 
involvement. Research supports the promise of SDM for enhancing engagement in post-acute 
treatment despite multiple levels of barriers. SDM interventions appear to be feasible yet more 
research is needed to empirically determine provider and patient opinions and feasibility in 
adopting these practices into a post-acute psychiatric crisis setting. Additionally, research on how 
patient preferences in decision making during the provider-patient dyad affect satisfaction with 
communication and care delivery will advance the practice of SDM in the seriously mentally ill 
population.  
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Objectives  
 
The overall objectives of this study are to investigate the association between the 
patient’s level of desire to participate in treatment decisions and demographic/clinical factors 
including, ethnicity, and degree of symptomatology and insight.  The study also examines how 
initial preference for decision-making style relates to how the initial visit with the prescriber is 
perceived by both the patient and the prescriber.  In addition, qualitative data on the use of a 
shared decision-making approach during post-acute psychiatric medication appointments is 
obtained. This study explores multi-level staff and patient opinions on the barriers, facilitators 
and feasibility of using shared decision making within a clinic setting, information not currently 
found in the published literature. In this effort, the study addresses the gap in research regarding 
the use of shared decision making within a seriously mentally ill population receiving post-acute 
psychiatric care. 
 
Conceptual Model  
 
Following the review of the literature, a conceptual model (Figure 4) was created to 
inform the proposed research that incorporates prior conditions and new research to complete 
Aims 1 and 2. Within the model, assumed components of SDM include prescriber training, SDM 
coaching, equality within the patient-prescriber dyad and patient-centered care. Other prior 
conditions include the knowledge base presented in the literature review on both barriers and 
strengths to SDM implementation. In Figure 4, the lower portion of this study’s conceptual 
model focuses on new research including all data gathered from qualitative interviews and 
existing quantitative data. The conceptual model also includes possible outcomes gleaned from 
the data analysis. The model additionally incorporates constructs from the chronic care models 
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previously presented and elements of the SDM literature review. Details specific to Aim 1 and 
Aim 2 are further explained.  
 
For Aim 1, previous literature reports data on the extent to which patients desire 
involvement in their own care and how this preference is related to age and gender. However, 
studies in the general population have been inconsistent with respect to these relationships.  
Additionally, it is unclear how these relationships will translate to an acutely mentally ill 
population. Moreover, there is little information on patient-prescriber agreement on 
communication during SDM medication visits and how this may relate to patient preferences or 
demographic characteristics. These are included in this study’s conceptual model (Figure 4) and 
will be addressed in the quantitative portion of this study.  
 
Regarding Aim 2, all three conceptual frameworks emphasize the need for patients to be 
actively involved in their own care. Wagner (1996) and Mulley (1990) specifically advocate for 
patient and provider education on treatment options. As part of clinic procedures, patients are 
provided SDM coaching, consisting of help to empower patients with the goal of enhancing 
patient communication skills, knowledge and options for communication with their prescribers. 
Clinic staff was trained in SDM practices including respect for the patient, equality within the 
dyad and patient-centeredness.  These key communication skill-building components also align 
with the IHI and Mulley’s (1990) recommendations to improve patient experiences, increase the 
exchange of information, and help empower the patient to be more involved in their own 
treatment decisions. Through the qualitative interviews (Aim 2), the concepts endorsed by 
previous medical frameworks will be investigated within a post-acute psychiatric population to 
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help improve the current knowledge gap within this population.  Time and resources associated 
with the delivery of SDM will also be explored in the qualitative interview portion of this study 
addressing the IHI construct of cost of healthcare and a possible barrier to SDM implementation.  
 
Figure 4. Conceptual Model of using Shared Decision making in Post-Acute Psychiatric 
Clinic  
 
 
METHODS 
Study Design 
 
This was a cross-sectional mixed methods study examining shared decision making in a 
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sample of individuals with severe mental illness who have recently been discharged from 
emergency rooms and inpatient psychiatric facilities. The specific aims were as follows: 
 
Aim #1: Characterize the demographic and clinical differences between groups of patients 
who desire differing levels of involvement in psychiatric decision making. 
 
Aim #2: Identify the factors influencing the use of a shared decision-making model in post 
psychiatric crisis care delivery.   
 
Study Site  
 
The study site was a Transitional Care Clinic funded by an 1115 Medicaid Waiver, area 
hospitals and charitable organizations.  Participants in the study were drawn from a convenience 
sample who participated in a research study examining outcomes in engagement-focused care 
versus usual care between the years of 2014 and 2016 (Patient-Centered Outcomes Research 
Institute (PCORI); Contract number: IH-1304-6506) as well as a de novo sample of individuals 
actively receiving treatment at The Transitional Care Clinic. The clinic provides a wide range of 
services including medication management, evidence-based psychotherapy and case 
management.  All clinic prescribers were trained in utilization of SDM within a patient-
prescriber dyad and general SDM practices for prior to data collection for the original parent 
study.  
 
Sample 
 
Aim 1 for the current was based on quantitative data collected at baseline as part of the 
27 
 
original parent study, but not analyzed to examine the questions proposed here. Aim 2 required 
the de novo collection and examination of qualitative interview data from current patient and 
clinic staff populations at the Transitional Care Clinic. These interviews were not part of the 
original trial but added by the PI (Maples) to enhance understanding of the main trial results. All 
aims for this dissertation are fully different than those of the original research study.  
 
The quantitative patient sample included a convenience sample of 258 individuals with 
severe mental illness who attended post-acute psychiatric hospitalization appointments at The 
Transitional Care Clinic during the original study.  Severe mental illness was defined as DSM5 
primary diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, depression, 
unspecified psychosis and unspecified mood disorder were included.  Due to the nature of this 
being the first clinic visit, some providers used an unspecified diagnostic category until more 
information regarding history and symptoms were clearer. Severe mental illness, rather than 
clinical diagnosis, defined the study population as research demonstrates that diagnosis is often 
unreliable and unstable over time and is a poor predictor of clinical outcomes (Cuthbert et al. 
2013).  By virtue of their acceptance into this clinic, participants are over 18 years of age, have 
been recently discharged from an inpatient psychiatric unit or triaged from an emergency room, 
and received a diagnosis of severe mental illness. and a diagnosis of severe mental illness as 
defined above.   
 
The patient sample for key informant interviews (Aim 2) was recruited at The 
Transitional Care Clinic. Trained clinic staff approached patients during routine medication visits 
at the clinic to obtain initial verbal consent allowing the PI contact them regarding the study.  
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The PI followed up to provide a full description of the study protocol and procedures.  If the 
individual agreed to participate, they were invited to partake in an interview at a time and date 
convenient to them. All interviews were completed at the clinic.  
 
Qualitative interviews were also conducted with clinic staff.  Additional key informants 
interviewed included clinic administrators, therapists, nursing staff and prescribers. Prescribers 
included a mixture of three psychiatrists and one nurse practitioner.  These clinic staff were 
approached via email by the PI and asked of their interest to participate in the study. If interested, 
the PI proceeded with a review of the study and scheduling the qualitative interview.  Study 
participation was voluntary and did not impact the person’s employment status or annual 
evaluation.  Interviewed staff were not supervised or under any authority of the PI.   
 
For patient interviews, sampling was deemed to reach saturation at 15 patients, or the 
point to which we had achieved informational redundancy. That is, no new information or 
themes were emerging from the data (Patton, 2002). Simple random sampling was used to 
identify a patient subset. There were approximately 300 eligible participants weekly with a 
diagnosis of severe mental illness seeking treatment at the transitional care clinic. A random digit 
was generated and clinic staff approached every fifth person based on the generated number. 
Staff continued to approach incoming patients until the desired number of 15 consented and 
interviewed subjects was obtained. 
 
Staff interviews were conducted with four prescribers (three psychiatrists, and one nurse 
practitioner), two therapists, one nurse and two clinic administrators following a semi-structured 
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qualitative interview.  All pertinent clinic staff were approached to participate in the interview. 
All approached staff agreed to the interview. The proposed staff sample size was small, due 
entirely to the number of employed staff members involved in patient treatment, but saturation 
was still reached with no new themes emerging after the ninth interview.  
 
Quantitative Assessments 
 
Demographic Data: Patient level demographic data available for the quantitative 
analyses included age (at time of baseline medication appointment), ethnicity, gender and 
diagnosis at time of first clinic appointment.  
In the quantitative portion of this study, we examined patient demographic and clinical 
characteristics at baseline in relation to the level of control an individual reported wanting to 
assume when decisions were being made about medical treatment. We additionally examined 
patient and prescriber quantitative ratings of prescribers’ in-session communication gathered 
after each baseline medication visit. Specific quantitative measures are described below.  
 
Control Preferences Scale (CPS). Patient preference for participation in SDM is an 
important potential moderator because not all patients wanted to play an active role in their 
treatment decisions. This domain is measured with the Control Preferences Scale (CPS; Degner 
et al, 1997; Appendices A & B). The control preferences construct is defined as "the degree of 
control an individual wants to assume when decisions are being made about medical treatment" 
(Degner et al, 1997). This scale presents patients with five cards that each present a statement 
describing a different role in decision making. Statements include: (A) I prefer to make decisions 
about which treatment I receive; (B) I prefer to make the final decision about my treatment after 
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seriously considering my doctor’s opinion; (C) I prefer that my doctor and I share responsibility 
about which treatment is best for me; (D) I prefer that my doctor make the final decision about 
which treatment will be used but seriously consider my opinion; (E) I prefer to leave all 
decisions regarding my treatment to my doctor. Cards were presented to the patient in pairs in a 
pre-specified order (B, D, C, A, and E) until the five statements are rank ordered. This 
assessment took approximately five minutes to complete. Sorting produced six different possible 
categorizations of how involved patients wanted to be in decisions. These included: 1) Active-
Active, 2) Active-Collaborative, 3) Collaborative-Active 4) Collaborative-Passive 5) Passive-
Collaborative and 6) Passive-Passive (Appendix A).  Note that all control preferences data had 
already been collected as part of the original study. For the purposes of the current study, we 
collapsed the six classifications into three: Active (Category 1-2), Collaborative (Categories 3-4), 
and Passive (Categories 5-6). 
 
The CPS is the most frequently used measure of patients’ preference for different levels 
of control in medical treatment decisions.  The psychometric properties of the CPS have been 
established across a variety of medical and behavioral health conditions and across languages 
and cultures. The measure is reliable across time and observer, has moderate internal 
consistency; and good convergent validity (Degner et al, 1997; De las Cuevas & Peñate, 2016; 
Singh et al, 2010, Garfield et al, 2007). 
 
Matched Pair Instrument (MPI). Patient and prescriber ratings of prescribers’ in-
session communication was obtained using the Matched Pair Instrument (MPI; Campbell et al, 
2007; Appendices C & D), a dyadic instrument comprised of 19 statements that assess the 
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content and process of a prescriber’s communication skills from each patient’s perspective. Each 
skill on the MPI is rated on a 5-point scale with higher scores indicating stronger agreement with 
the statement. The prescriber and patient completed a version immediately following the 
encounter.  A total score for each participant is derived. In addition, a difference score between 
provider and patient ratings was calculated.  The absolute value of this score reflected the 
average distance between patients and providers in their perceptions of communication during 
the session.  Campbell et al (2007) demonstrate good internal consistency and reliability of this 
scale over time and a systematic review of 20 measures of physician-patient communication 
evaluated the psychometric properties of the MPI as similar to other instruments assessing this 
construct.  However, the review recommended further psychometric testing for all of the 
instruments reviewed.  In part, the MPI was chosen over other possibilities due to the evaluation 
of the advisory board for the transitional care clinic. They recommended the MPI as being 
relatively simple for patients to complete and having high acceptability. 
 
Expanded Brief Psychiatric Rating Scale (BPRS).  The Expanded Brief Psychiatric 
Rating Scale (BPRS) was used to characterize psychiatric symptoms amongst patients the 
(Ventura et al, 1993; Appendix E). This scale is a 24-item interview-based measure that captures 
a range of psychiatric symptoms rated on 7-point Likert scales, with higher scores indicating 
more severe symptomatology.  This scale is summed to yield a total score and four factor scores 
(agitation-mania, depression-anxiety, positive symptoms, and negative symptoms; Appendix F). 
Positive symptoms refer to an excess or distortion of normal function. Examples include 
hallucinations and delusions. Negative symptoms refer to a decrease or absence of normal 
function. Examples include lack of/reduced emotion, loss of interest and apathy. The reliability 
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of BPRS over time and across raters has been established over decades of use (Ventura et al, 
1993). The instrument has been validated across a variety of languages and cultures (Shafer et al, 
2017). In addition, the measure is sensitive to change in treatment and correlates with global 
measures of psychopathology such as the Clinical Global Impression (Leucht et al., 2006). 
 
Scale to Assess Unawareness of Mental Disorders (SUMD). The abridged version of 
the Scale to Assess Unawareness of Mental Disorders (SUMD; Amador et al, 1994; Appendix 
G) was used to measure patient insight into having a psychiatric illness. This semi-structured 
open interview evaluates three items including global insight, insight into illness and insight into 
symptoms on a 5-point Likert scale with higher scores indicating lower insight. The SUMD is 
widely used in clinical trials and epidemiological studies and the abbreviated version has 
demonstrated good internal consistency and external validity (Michel et al, 2013). 
 
Qualitative Assessments 
 
We conducted semi structured open-ended interviews with both clinic staff and current 
patients attending The Transitional Care Clinic.    
 
Patient and Staff interviews 
Interviews for patient participants were conducted by the principal investigator (Maples) 
and lasted approximately 30-40 minutes.  They were conducted in person in the clinic and patient 
participants were paid for their time.   Prior to the interviews, the PI explained the purpose of the 
interview and the importance of open sharing of opinions.   
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The interview was developed by the PI in collaboration with experts in the Department of 
Psychiatry, and the stakeholder advisory board of the Transitional Care Clinic to address specific 
themes in the theoretical model.  It follows a semi-structured format which began with general 
open-ended questions regarding the patient’s experiences with mental health care and proceeded 
to more specifically address shared decision making and its impact upon care.  Topics addressed 
included the patients’ experiences with satisfaction with prescriber interaction and impact of the 
SDM process on medication visit outcomes. Both the staff and patient versions of the interview 
guide can be found in Appendices H and I, respectively. Interviews were audio recorded and all 
audio tapes were transcribed by research staff. Audio files were permanently deleted after 
transcription.   
 
Clinic staff participants were interviewed using a semi-structured interview schedule 
developed by the PI in conjunction with experienced researchers in the Department and the 
stakeholder advisory board of the transitional care clinic.  Important domains were identified and 
agreed upon, summarized by the PI, and collated into a semi-structured interview guide.  The 
interview guide consists of questions about staff experiences using shared decision making as a 
practice within the transitional care clinic, including feasibility and utility. The interviews were 
carried out by the PI and lasted approximately 30 minutes. Interviews were conducted in person 
at the staff member’s office.    
 
Avoidance of bias 
Selection bias during qualitative interviews is a possibility. Patients who agree to 
participate in the qualitative interviews may feel more emotional, either good or bad, about the 
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treatment at the crisis clinic.  Information bias, a bias arising from measurement error, is also a 
consideration. This is possible with self-report data resulting in a differing quality, or amount of 
accuracy, in information between the three comparison groups. Information bias is also possible 
from the staff sample, again due to self-report data affecting the accuracy of information 
obtained. Another potential confounding variable needing consideration is provider’s level of 
shared decision making during actual practice. While all providers have been equally trained in 
the SDM process, providers use different methods based on their own medical training, personal 
beliefs or years’ experience. An additional confounder includes the severity of acute 
exacerbation within the patient population. While all patients attending the Transitional Care 
Clinic have recently been discharged or averted from a psychiatric hospitalization, there are 
differing levels of symptom severity (i.e. suicidal ideation versus suicide attempt) which may 
affect the desired level of involvement in the patient-provider dyad and the perception of the 
encounter. 
  
Data Management 
 
All extant quantitative data was entered into a relational database meeting HIPAA 
requirements, using software that provides for double entry and numerous internal validity 
checks. All data are stored in HIPAA compliant password protected computer databases by 
subject numbers. No identifying information such as social security numbers, names or 
birthdates are included in the database. Data is maintained and backed up daily to prevent data 
loss and ensure full data retrieval for analyses. Security is maintained through a network 
manager.  Quantitative data was analyzed using the Statistical Analysis Software (SAS version 
9.3; SAS; Cary Institute).   
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Data Analysis 
 
Quantitative Data Analysis 
For analysis of quantitative data, we combined categories from the Control Preferences 
Scale into three larger groups reflecting their preferred SDM style; 1) Active, 2) Collaborative 
and 3) Passive. The primarily Active Group includes those patients who fell into either the 
Active-Active or Active-Collaborative categories. These patients tend to prefer to make most of 
the decisions with very little or no input from the doctor. The Collaborative Group includes 
patients who fell into either the Collaborative-Active or Collaborative-Passive categories. These 
patients prefer a very collaborative interaction where decisions are equally based on doctor 
patient input. The primarily Passive Group includes those patients who fell into either the 
Passive-Collaborative or Passive-Passive categories. These patients prefer interaction where their 
doctor has the majority of weight in decision making. 
 
Chi square analyses were used to examine group differences (Active/ Collaborative/ 
Passive) by gender and ethnicity to determine whether there is an increased likelihood that one 
gender or specific ethnic groups have a preference for specific styles of medical decision 
making. One-way analyses of variance were used to examine CPS group differences 
(Active/Collaborative/Passive) on continuous measures including age, BPRS total score, BPRS 
factor scores, insight into having a psychiatric illness (SUMD total score), MPI difference scores 
and MPI patient rating. All tests were two-tailed. Demographic and clinical data are used to 
determine if differences exist between groups of patients who desire differing levels of 
involvement in psychiatric decision making. The measures specific to SDM allow us to examine 
36 
 
how patients view the initial encounter with prescribers, and the extent to which their view of the 
encounter differs from that of the prescriber.  
 
Sample size and Power Analysis 
A power analysis was conducted on categorical and continues variables in a group of 
258, split into three unequal groups - Active, Collaborative and Passive, representing 
approximately 26%, 53% and 21% of the population, respectively. The power analysis on fixed 
effect in the analysis of variance and covariance, with three groups, a total subject size of 258, 
and effect size of 0.2, the power of the F test on means at α=0.05 criterion is 0.82. This indicates 
we have sufficient power to detect differences across the three groups created from the control 
preferences scale (Cohen, 1988).  
 
Qualitative Analysis  
To analyze interview data, we use an iterative process that consists of three steps: 
“noticing, collecting, and thinking” (Seidel, 1998). Interviews were audio recorded and 
transcribed by research staff and were coded by the PI and another faculty member in the same 
University and Department. Latent thematic analysis was used to analyze this exploratory data 
(Braun & Clarke, 2006) and NVivo 12 software was used to organize the data (NVivo 12, QSR 
International Pty Ltd, 2018). Each participating group (patient and provider) was analyzed 
independently and then the group data were combined. Using inductive category development, 
the codes from all transcripts were thematically clustered to serve as the basis for higher level 
categories, of which there were 12. Inductive categorization allowed for coding the data without 
trying to fit it into a pre-existing coding frame, or the researcher’s analytic preconceptions 
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(Braun & Clarke, 2006). This flexible method is used to identify patterns of meaning within data 
among participants and is not allied to any particular framework. We looked for themes 
especially relevant to differences in experiences of and preferences for SDM (e.g. desired 
balance of power); satisfaction with provider visits, including length of visits; how previous 
experiences affect current desire for and use of SDM; and consequences of not using an SDM 
approach. All codes were then grouped into these categories by the two researchers. Following 
thematic latent analysis (Braun & Clarke, 2006), the 12 semantic categories were further 
analyzed at the latent level to identify higher order themes, of which there were six. Any areas of 
disagreement were resolved by discussion until consensus was reached.  
 
Sample size for Qualitative Analysis 
Sample size for patient interviews is projected to reach saturation at n=15. Sample size 
for the staff interviews are set by number of current staff members.   
 
Strengths and Limitations of the Study 
 
This study contributes to the limited published literature on shared decision making 
within the mental health field. Additionally, this is the first evaluation of the perceptions and 
preferences of individuals with serious mental illness and their providers regarding SDM in a 
clinic serving a population immediately following a psychiatric crisis or hospitalization.  
Strengths in this study include the sample size of the quantitative data, psychometric properties 
and variety of the quantitative assessments, in depth interview guides and the use of two coders 
for qualitative data.  
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While there are many strengths to this study, limitations are also present. In the 
quantitative analyses, the data is retrospective and we are unable to add to the current sample. 
Additionally, we are limited to the baseline visit without any follow up data for these 
participants. The cross-sectional nature of this study does not allow for examination of difference 
in SDM styles over time. A relatively smaller percentage of African American study participants 
make it difficult to generalize from these results. In addition, all qualitative interviews are  
performed in one clinic. Interviewing patients and providers in different areas may extend the 
variability of responses.  
 
Human Subjects and Safety Considerations 
 
The safety of participants was monitored using procedures developed in the Division of 
Community Recovery, Research and Training over decades.  Detailed training in good clinical 
practice and informed consent procedures helps to ensure appropriate protection of human 
subjects. The principal investigator has been trained in clinical research interview techniques, 
including methods to obtain data in a non-threatening manner. All subjects, including staff, are 
told they are free to withdraw from participation in the interview at any time. The principal 
investigator has twenty years’ experience working with individuals with severe mental illness, 
including expertise in semi-structured interviews with this population, and has trained more than 
50 staff in maximizing participant confidentiality and comfort.  Prior to participating in the 
PCORI study all patients went through an informed consent process which included an 
assessment of the ability to give consent.  Potential participants needed to answer specific 
questions to determine whether they understood the study and what would be expected of them.  
If they were unable to correctly answer these questions, some additional training was provided.  
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If potential participants were still unable to answer questions, they were not allowed to sign 
informed consent for the study. 
 
Sources of Research Material. We examined data collected as part of the original PCORI study 
and we collected information from subjects via in person interviews. All data collected is used 
for the purpose of research.   
 
Recruitment 
For Aim 1, no recruitment occurred as preexisting data was be used. For Aim 2, 15 
patients were interviewed. Trained clinic staff familiar with the patients requested initial patient 
participant consent during in-person medication visits to The Transitional Care Clinic. For 
further description of the study, including full consenting procedures, the principal investigator 
followed up with those giving verbal consent. Individuals were invited to participate in an 
interview at a time and date convenient to them. Nine clinic staff members were interviewed. 
Provider participants were recruited via email from the PI requesting participation in the study. 
Staff were informed of the purpose of the interview and accepting staff were interviewed in their 
office at a time and date convenient to them.  
 
Informed Consent    
The research study was deemed exempt by UT Health San Antonio’s Institutional 
Review Board (IRB) due to no collection of identifying information. The consent form would 
have been the only piece of identifying information able to be tied back to either patient or staff 
participants.  As such and per the request of the IRB, the PI created a checklist of pertinent 
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information of the study and this checklist was presented to the participants. Each participant 
was given a checklist to take with them including the contact information of the PI should they 
have questions after the interview.   The 24 participants were asked to participate in an interview 
about shared decision making.  They all provided verbal consent to audio record the interview 
and were made aware that transcripts of the audio tapes were made. Participants were informed 
that no identifying information was retained and only an identification number would appear on 
the transcript.  All participants were informed that to further protect confidentiality; audio tapes 
were to be erased following transcription.   All participants were informed that only researchers 
had access to the tapes and transcripts; no others involved with the Transitional Care Clinic or 
UT Health San Antonio are aware of their answers, and their responses cannot affect their status 
in at the Transitional Care Clinic or employment at UT Health San Antonio.  
 
The existing quantitative data used in this dissertation was gathered from a preexisting 
PCORI-funded research study. All subjects signed an informed consent form and the study was 
approved by UT Health San Antonio IRB.  
 
Confidentiality 
Participant information will not be shared with anyone outside the research team.  
Participants were not identified by name during the taping.  A study ID is attached to each 
participant’s transcript.  All participant information from the original trial is contained in a 
HIPPA compliant database with no PHI attached. 
 
Compensation   
41 
 
Patients participating in qualitative interviews were paid $30 for their time. Clinic staff 
participating in qualitative interviews were not be reimbursed for their time. Interviews were 
conducted during normal business hours and is intended to further the knowledge of the research 
within this topic area for future publication and possible grant applications, dependent on 
findings.  
 
Potential Risks and Procedures to Minimize Risks   
Risks of study procedures can include distress and heightened sensitivity that can occur 
as part of participation in clinical interviews; and potential breaches in confidentiality.  While the 
possibility of such events is low given the procedures taken to minimize risk, the PI monitored 
these situations.  The potential for these risks was reduced by adherence to guidelines of good 
clinical practice and formal supervision and training of personnel. If subjects became upset when 
discussing their treatment, the PI was available to consult with them.  
  
Information is not be disseminated without the patient’s written consent. Case records are 
kept in a secure location in password-protected files. Access to these files is restricted only to our 
research staff. Computer based information is identified by numbers and codes only. No names 
appear in the data files. The database is password protected. The risks to patients in this study are 
balanced by the importance of the information that will be obtained on treatments to improve 
mental health outcomes. We have used similar assessment procedures for more than 2 decades. 
The PI and research staff are experienced in conducting trials with individuals with serious 
mental illness.  
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The analysis proposed is presented in two formatted journal articles.  Each will follow author 
instructions from a peer-reviewed journal and will be presented as a full paper.  These will be 
followed by a chapter that will summarize the two papers and the implications for practice.   
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JOURNAL ARTICLE I 
 
Patient Preferences in Decision Making within a Post-acute Psychiatric Clinic 
 
To be submitted to Patient Preferences and Adherence Journal 
  
44 
 
Abstract 
Severe mental illness in adults refers to a group of mental health conditions including 
schizophrenia and schizoaffective, bipolar and major depressive disorders. These conditions are 
often characterized by recurring symptoms, multiple hospitalizations, and significant disability. 
The public health concern with these conditions is amplified because many individuals with 
severe mental illness fail to engage in outpatient treatment. Desperately needed are ways to 
support greater rates of participation in outpatient treatment. Encouraging participation in 
medical decision-making is viewed as one method to optimize patient empowerment, increase 
engagement in care and decrease the negative outcomes that often characterize this 
population. Shared decision-making is a collaborative and structured approach to patient-
provider communication viewed as a negotiation between mutual experts with the goal of 
balancing empirical information with patient values and preferences. As part of an engagement-
focused research study, data on decision making preferences and a variety of clinical, 
demographic and communication variables were collected from 258 individuals with severe 
mental illness during a baseline visit at a clinic serving individuals immediately after hospital 
discharge. The association between clinical, demographic and communication characteristics and 
patients’ self-reported decision-making preference (active, collaborative, or passive) were 
examined using chi square and one-way analyses of covariance. Results indicated that 
race/ethnicity was significantly associated with SDM preference group, with African American 
individuals desiring more active participation in decision making compared to their Hispanic 
counterparts. Other characteristics including age, gender, symptom acuity, diagnosis, insight into 
illness, patient and provider agreement on communication during the visit and patient rating of 
communication during the visit were not significantly associated with the patient’s baseline 
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decision-making preferences in this context. These findings indicate race/ethnicity may be an 
important factor when using a shared decision-making approach. More research is needed to 
determine how decision-making preferences relate to other clinical or situational factors. 
 
Keywords: Severe Mental Illness, Mental Health, Shared Decision Making, Control Preferences 
Scale, Transitional Care Clinic 
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Introduction 
 
Severe mental illness in adults refers to a group of mental health disorders often defined by 
length of illness duration and the resulting functional impairment it produces. These illnesses 
include disorders that produce psychotic symptoms, such as schizophrenia and schizoaffective 
disorder, and severe forms of affective disorders, such as major depression and bipolar disorder.1 
It is estimated that 4.6% percent of the United States adult population is diagnosed with one of 
these conditions at any given time.2 Severe mental illness is one of the leading causes of 
disability worldwide according to the global burden of disease disability weights. 3,4 The course 
of this group of disorders is often characterized by recurring exacerbations and multiple 
hospitalizations.5  
 
The per patient lifetime burden of serious mental illness is estimated at $1.85 million.6  Services 
with the highest costs include hospitalization and emergency department visits. In an extensive 
review of psychiatric admissions to 418 U.S. community-based hospitals, the three most 
common diagnoses included depression (27.8%), schizophrenia/schizoaffective disorder (19.5%) 
and bipolar disorder (19.4%).7  These diagnoses are included in the broader category of severe 
mental illness. Typical psychiatric hospitalizations for individuals living with severe mental 
illness last only a few days (x̅ = 4.4 – 11.1),7 while many still experience severe psychiatric 
symptoms at the time of discharge. The recurring hospitalization and emergency care 
utilization—as part of ongoing illness management coupled with an over-burdened outpatient 
mental health service care system8—result in as many as one-half of these individuals failing to 
connect to sustained outpatient care.9  This places patients at greater risk of numerous negative 
outcomes, including repeated emergency department visits and inpatient hospitalizations, 
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homelessness, violence against others and suicide.10,11 According to Pasic and colleagues 
(2005),12 high utilization of hospital and emergency services points to quality of care and access 
problems in outpatient care that must be addressed. To this effect, it has been suggested that 
these negative outcomes may decrease within the mental health population if patients have more 
involvement in psychiatric decision making.13,14 Correspondingly, engagement in outpatient 
services may be enhanced with a higher level of patient empowerment within the patient-
physician dyad.15  
 
Various intervention approaches have been used to increase follow-through attendance at 
outpatient treatment,16 but most methods do not emphasize the importance of patients 
participating in their own treatment decisions. Shared Decision Making (SDM) is an exception. 
SDM is a structured method to patient-provider communication in medicine that frames the 
interaction as a negotiation between mutual experts and stresses the balanced use of empirical 
information and patient preference in decision making.17 SDM is a systems approach to enable 
continuous improvement in clinical decision making.18 The model focuses on two key 
participants, the patient and provider. There is a fundamental social nature in the decision-
making task that cannot be completed by the doctor or patient alone, but rather requires 
productive interactions and communication between them. In a shared decision-making model, 
clinical providers are primarily responsible for knowing and appropriately applying the 
knowledge base. Patients are primarily responsible for contributing well-informed subjective 
assessments of possible health states relevant to decisions and for reporting outcomes and 
experiences with, and assessment of, these health states. Patients are additionally tasked with 
providing their values and preferences related to medical decisions. The responsibility placed 
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upon key participants is high, but that responsibility also lies at the center of success in such a 
model. Additionally, current clinical practice guidelines advocate for all clinicians, regardless of 
public health sector, to involve patients in decision making processes and allow for patient 
preferences, along with the evidence, to guide decisions where possible. 
 
Research on SDM in psychiatry has received support through the New Freedom Commission on 
Mental Health,19 and other government policy reports.20,21 SDM may be of particular benefit in 
severe mental illness because of low follow-through with treatment due to factors including 
dissatisfaction with side effects from antipsychotic and mood stabilizing medications, poor 
insight into illness, and functional and motivational impairments. Despite these challenges, the 
majority of people experiencing mental illnesses express a desire to participate in making 
decisions regarding medications and hospitalizations,22-25 and there is evidence that adults with 
severe mental illness frequently make competent and prudent treatment decisions.26,27 Drake and 
colleagues (2010)28 pose that SDM is an essential component in treatments focusing on recovery 
for individuals with severe mental illness, calling it an ethical imperative. Despite the apparent 
promise of SDM, there is a low level of adoption and implementation of this practice within the 
mental health care delivery system, relative to other areas of medicine. Efforts to increase patient 
involvement in care decisions face barriers such as overworked physicians, insufficient provider 
training, deficient medical information systems, physician time constraints, perceived lack of 
efficiency in the practice, a deemed lack of applicability due to patient characteristics and 
symptoms, and inappropriate clinical situations.29,30  Slade (2017)31 also cites a lack of support 
tools, integration of SDM with other recovery‐related interventions, and sensitivity to cultural 
changes as problematic for SDM implementation in mental health. 
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At the patient level, demographic characteristics may make someone more or less interested in 
participating in this collaborative approach. In a review of patients’ preferences for involvement 
in decision making, research revealed demographic variables, including being younger, better 
educated and female were consistently found to be associated with a preference for a more active 
role in decision making.32 However, in a comparison of older and younger individuals with 
severe mental illness, it was concluded older persons have a stronger desire for involvement in 
decision making than do their younger counterparts.23 Demographics related to decision making 
preferences within this population remain unclear.  
 
A better understanding of the factors related to shared decision-making styles for different 
patients, and a better understanding of issues related to its implementation may be critical to 
maximizing individual patient outcomes. Currently, there is insufficient evidence on how much 
involvement individuals with severe psychiatric conditions desire to have in their patient-
provider interactions regarding psychiatric care decisions. While previous studies have found 
factors such as age and gender to impact the desired level of involvement in care, results are 
inconclusive. Moreover, there is no evidence to date on how factors such as the level of 
psychiatric symptomatology, level of insight and ethnicity are related to patient’s preference for 
involvement in the process of treatment decisions. A Cochrane review on the use of SDM in the 
mental health population highlighted the necessity for more research in this area.33  
 
Materials and Methods 
 
Setting and Design 
The study site was the Transitional Care Clinic (TCC) providing a wide range of services to 
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individuals recently discharged or deferred from a psychiatric hospital or crisis setting. Services 
provided include medication management, evidence-based psychotherapy and case management 
for individuals with severe mental illness. Between the years of 2014 and 2016, a research study 
was conducted on the effects of engagement-focused care versus usual care (Patient-Centered 
Outcomes Research Institute (PCORI); Contract number: IH-1304-6506). A key component in 
engagement-focused care was training in, and use of, SDM practices by all clinic providers prior 
to study initiation. As part of the engagement-focused research, data on decision-making 
preferences and a variety of clinical, demographic and communication variables were collected 
from 258 individuals with severe mental illness during a baseline visit at a clinic serving 
individuals immediately after hospital discharge.  
 
Participants 
 
The patient sample included a convenience sample 258 individuals with severe mental illness 
who attended a post-acute psychiatric hospitalization appointment at the Transitional Care Clinic 
as participation in the parent study. By virtue of their acceptance into this clinic, participants are 
over 18 years of age, have been recently discharged from an inpatient psychiatric unit or triaged 
from an emergency room, and received a diagnosis of severe mental illness. One participant was 
missing over half of the study data and was excluded from analyses. Patient follow-up 
appointments at the clinic typically occurred 1-14 days post discharge. Severe mental illness is 
defined as a Diagnostic and Statistical Manual of Mental Disorders – 5th Edition (DSM-5)34 
primary diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder (with and without 
psychotic features), depression (with and without psychotic features), unspecified psychosis and 
unspecified mood disorder. The analyses of pre-existing data for this research study was 
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approved by both the UT Health Houston Committee for the Protection of Human Subjects and 
the UT Health San Antonio Institutional Review Board.  
 
Data Sources and Measures 
 
Demographic Data: Patient level demographic data available for analyses included age, ethnicity, 
gender and diagnosis as charted at the time of first clinic appointment immediately following 
hospital discharge.  
 
Control Preferences Scale (CPS). Patient preference for participation in SDM is was measured 
with the Control Preferences Scale.35 The control preferences construct is defined as "the degree 
of control an individual wants to assume when decisions are being made about medical 
treatment".35  This scale presents patients with five cards that each present a statement describing 
a different role in decision making. Statements range from, I prefer to make decisions about 
which treatment I receive to I prefer to leave all decisions regarding my treatment to my 
doctor. Cards are presented to the patient in pairs in a pre-specified order (B, D, C, A, and E) 
until the five statements are rank ordered. Sorting produces six different possible categorizations 
of how involved patients want to be in decisions. These include: 1) Active-Active, 2) Active-
Collaborative, 3) Collaborative-Active 4) Collaborative-Passive 5) Passive-Collaborative and 6) 
Passive-Passive. For the purposes of the current study, we collapsed the six classifications into 
three: Active (Category 1-2), Collaborative (Categories 3-4), and Passive (Categories 5-6). For 
analysis of control preference data, we combined categories from the Control Preferences Scale 
into three larger groups reflecting their preferred SDM style; 1) Active, 2) Collaborative and 3) 
Passive. The primarily Active Group includes those patients who fell into either the Active-
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Active or Active-Collaborative categories. These patients tend to prefer to make most of the 
decisions with very little or no input from the doctor. The Collaborative Group includes patients 
who fell into either the Collaborative-Active or Collaborative-Passive categories. These patients 
prefer a very collaborative interaction where decisions are equally based on doctor patient input. 
The primarily Passive Group includes those patients who fell into either the Passive-
Collaborative or Passive-Passive categories. These patients prefer interaction where their doctor 
has the majority of weight in decision making.  
 
Matched Pair Instrument (MPI). Patient and prescriber ratings of prescribers’ in-session 
communication was obtained using the Matched Pair Instrument36 a dyadic instrument 
comprised of 19 statements that assess the content and process of a prescriber’s communication 
skills from each patient’s perspective. Each skill on the MPI is rated on a 5-point scale with 
higher scores indicating stronger agreement with the statement. The prescriber and patient 
completed a version immediately following the baseline study encounter. A total score for each 
participant is derived. In addition, a difference score between provider and patient ratings was 
calculated. The absolute value of this score reflected the average distance between patients and 
providers in their perceptions of communication during the session.  
 
Expanded Brief Psychiatric Rating Scale (BPRS). The Expanded Brief Psychiatric Rating Scale 
(BPRS) was used to characterize psychiatric symptoms amongst patients37 This scale is a 24-
item interview-based measure that captures a range of psychiatric symptoms rated on 7-point 
Likert scales, with higher scores indicating more severe symptomatology. This scale is summed 
to yield a total score and several factor scores (depression-anxiety, positive symptoms, and 
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negative symptoms).  
 
Scale to Assess Unawareness of Mental Disorders (SUMD). The abridged version of the Scale to 
Assess Unawareness of Mental Disorders38 was used measure patient insight into having a 
psychiatric illness. This semi-structured open interview evaluates three items including global 
insight, insight into illness and insight into symptoms on a series of 5-point Likert scales with 
higher scores indicating lower insight.  
 
Data Analysis 
 
Univariate descriptive statistics included means with standard deviation and frequencies for all 
variables. For analysis of control preference data, we combined categories from the Control 
Preferences Scale into three larger groups reflecting their preferred SDM style; 1) Active, 2) 
Collaborative and 3) Passive. We present numbers (percentages) of participants in each of the 
three collapsed control preference groups.39 
 
Chi square analyses were used to examine Shared decision-making classification 
(Active/Collaborative/Passive) by gender (Male/Female) and ethnicity (name here) to determine 
whether there was an increased likelihood that one gender or specific ethnic group preferred 
specific styles of medical decision making. As only four patients classified their race as “other” 
or “mixed” (causing expected frequencies in the associated cells to be too low), we excluded this 
group and the “unknown” group from subgroup interaction analyses, focusing the examination 
on the relationship between race/ethnicity (non-Hispanic white, Hispanic, African American) and 
the three SDM control preference groups (Active, Collaborative, and Passive).  
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To test the main effects and interaction one-way analyses of covariance were used examining 
control preference group differences (Active/Collaborative/Passive) on continuous measures 
including age, clinical symptomatology (BPRS total score and subscale scores), insight into 
having a psychiatric illness (SUMD total score), matched pair difference scores and matched pair 
patient ratings. All tests were two-tailed. Demographic and clinical data were used to determine 
if differences exist between groups of patients who desire differing levels of involvement in 
psychiatric decision making. The measures of communication allowed for examination of how 
patients view the initial encounter with prescribers, and the extent to which their view of the 
encounter differs from that of the prescriber.  
 
Results 
 
The sample was 45.4% male (117/257); with a mean age of 38 (S.D. 11.9). 50% were Hispanic 
(129/258), 38% non-Hispanic white (99/257), 8% African American, and 3% other or unknown 
(8/257). Almost 40% were diagnosed with major depressive disorder (103/257), followed by 
30% with bipolar disorder (78/257), 16% with unspecified mood disorder (42/257) and 14% with 
schizophrenia and related disorders (including schizoaffective disorder and unspecified 
psychosis; 35/257). Twenty-six percent (68/257) of the sample identified as having active control 
preferences – desiring all or most decision-making responsibility, 53% (137/257) as 
collaborative – sharing most decision-making opportunities, and 21% (53/257) as passive - 
ceding most or all decision making to the provider. Demographic characteristics and SDM 
control preference categories are summarized in Table 1.1  
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Table 1.2 presents a breakdown of SDM preferences by race/ethnicity. Race/ethnicity 
demonstrated a significant relationship with patient control preference group (X2 (4; N=257) 
=10.18, p =0.0375). A significant difference was found in medical related control preferences 
between African American and Hispanic individuals, with African American individuals 
preferring a more active role than did their Hispanic counterparts (X2 (1; N=249) =3.97, p 
=0.0463). Odds ratio estimates revealed African American individuals are 4.17 times more likely 
than are Hispanic individuals to be in the Active group (1/.241=4.17). No significant differences 
were found for control preferences between Hispanic and non-Hispanic whites or between 
African Americans and non-Hispanic whites. 
 
No other demographic or clinical variables investigated distinguished the control preference 
decision-making groups. We examined the contribution of gender, age, clinical symptomatology 
(BPRS total and depression-anxiety, positive symptom and negative symptom subscales), 
diagnosis, patient rating of communication satisfaction, and patient/provider communication 
satisfaction agreement and found no significant relationships to SDM preferences (all p values > 
.o5*).  A multinomial logistic regression with stepwise selection was then used to include 
variables with a 0.3 significant level for entry into the model. No differences were found 
between the three control preference groups by gender (X2 (2; N=257) =0.643, p =0.725), age (X2 
(2; N=257) =0.089, p =0.957), depression-anxiety subscale (X2 (2; N=257) =2.238, p =0.327), 
positive symptom subscale (X2 (2; N=257) =3.979, p =0.137), negative symptom subscale (X2 (2; 
N=257) =0.246, p =0.884), patient communication satisfaction (X2 (2; N=257) =0.466, p 
=0.792), or provider-patient communication satisfaction (X2 (2; N=257) =0.821, p =0.664). 
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Discussion 
 
This study contributed to the limited published literature on shared decision making within the 
mental health field. Additionally, this is the first study to investigate the medical decision control 
preferences in a group of individuals receiving mental health treatment immediately following 
hospital discharge. Race/ethnicity is an important factor when using a shared decision-making 
approach. African American individuals were more likely to want to be active or collaborative 
contributors in the medical decision-making process. There is a complex history of race in the 
medical profession. Doctors have historically been Caucasian and there is a history of 
exploitation of African American Americans as well as perhaps engaging this population with 
directives rather than dialogue. This may have led this population to be more suspicious of 
providers and, consequently, the desire to more actively participate in medical decision-making. 
Many disparities are reported in the area of mental health when comparing African Americans to 
whites, including higher levels of incorrect diagnoses, underrepresentation in research, less 
access to treatment, more severe symptom ratings, greater functional impairment once 
diagnosed, and significantly fewer African Americans seeking treatment.40-43  Additionally, 
Eliacin et al (2016)44 reports African Americans are less likely to be engaged in treatment and 
often perform more poorly on healthcare activities linked to patient engagement, such as 
communicating effectively with providers and participating in treatment decisions. To this end, 
active engagement and participation in mental health treatment may represent an important 
component in addressing many of these inequalities. For example, providers may work to 
increase patient activation by asking patients to define their goals for mental health treatment 
including the steps needed to achieve them and identify patient knowledge gaps so further 
education can be offered. In contrast to African Americans, Hispanic individuals were more 
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likely to choose a passive role in decision-making. From a historical perspective, Hispanic 
individuals tend to be respectful of authority and more likely to adhere to a perceived power 
gradient, making them more likely to cede decision making to a medical provider.45,46 Research 
indicates Hispanics are more deferential to authority figures, depending on acculturation, and are 
less likely to engage in mental health treatment than whites.47  For these reasons, Añez et al 
(2008)48 proposed the application of motivational interviewing principles to Latino cultural 
values and emphasizes the need to promote a client-centered and culturally congruent therapeutic 
environment to improve the connection to and participation of these individuals. Markowitz et al 
(2009)49 suggests minimizing the emphasis of the medical diagnosis and recognition of the 
centrality of family as necessary cultural adaptations when treating Spanish-speaking individuals 
with depression. Providers may also work to improve their Hispanic patients’ self-efficacy in 
making sound medical decisions by dividing tasks and offering feedback and reinforcement for 
each aspect of illness self-management. It is evident that baseline decision making preferences 
need to be considered when providing mental health care. Patients of all races/ethnicities need to 
be aided on how to engage in the process of SDM and providers need to ensure they 
communicate the importance of active and collaborative participation, even in situations that 
may be new for individuals in treatment. This may involve recognizing the patient’s knowledge, 
allowing sufficient time for participation or explaining the benefits of participating in treatment 
including improved health outcomes and better quality of life.50 In line with the emerging 
paradigm of patient-centered care, culturally appropriate decision making needs to be 
emphasized. This may include decision aids and coaching manuals with culturally congruent 
language and examples and further training for mental health professionals. 
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Race/ethnicity is an important consideration when using a shared decision-making approach, yet 
other demographic, clinical and communication characteristics were not predictive of control 
preference style in this context. It may be other factors are more important in determining the 
extent to which someone wants to contribute in psychiatric decision making. The participants in 
this study had in common a recent acute psychiatric hospitalization or crisis. Perhaps given this 
often traumatic and stressful event, other characteristics, such as age, gender and symptom acuity 
become less important as related to shared decision-making preferences.  In a review of non-
psychiatric patient preferences for involvement in medical decision making, Say et al (2005)32 
report demographic variables, including being younger and female as consistently associated 
with a preference for a more active role in decision making. These findings were not 
corroborated in this study, although it may hold true for the general population. Other possible 
explanations not explored in this study include previous experiences in the mental health system, 
including hospitalizations, and personality traits.  
 
Previous experiences with the mental health system may affect how individuals interact with 
current and future providers of care. In a group of 588 individuals with severe mental illness in 
Europe, Cosh et al (2017)40 report a significant association between active (versus collaborative 
or passive) involvement in decision making and longer hospitalization durations. 
Correspondingly, these authors report patient-rated preferences for passive or shared decision 
making styles were associated with shorter hospital admissions.40 This finding suggest that 
patients with less severe illnesses, who are less likely to have inpatient admissions, prefer sharing 
decision making with providers while those with more severe illnesses prefer additional input in 
decisions. The number and length of previous hospitalizations were not evaluated in this study 
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and future research should examine whether active decisional preference is a marker of patients 
who are less well or whether there is a causal association between active decision preferences 
and more hospital admissions.  Apart from experiences in the mental health system, research 
suggests personality traits such as, extraversion, agreeableness, conscientiousness, neuroticism, 
and openness to experience are related to desire to make medical decisions.51 Flynn (2007)52 
found that higher rates of conscientiousness and openness to experience and lower levels of 
agreeableness and neuroticism related to preferring the most active decision-making style 
compared with the least active decision-making preference.  These studies demonstrate the need 
to examine personality characteristics when studying decision-making preferences.  
 
Limitations 
 
Multiple tests of statistical significance were utilized in these analyses and may have increased 
the likelihood that the relationship between race/ethnicity and control preference group was due 
to chance. The cross-sectional nature of this study did not allow for examination of difference in 
SDM styles over time. A relatively smaller percentage of African American study participants 
make it difficult to generalize from these results. The control preference groups were determined 
by one self-reported assessment. While the Control Preferences Scale is a validated instrument, it 
is possible that more sensitive scales or use of more than one scale is needed. 
 
Conclusion 
 
Despite the limitations described above, the study highlighted that SDM preferences are different 
across individuals in this treatment setting. These preferences need to be considered in 
approaching SDM education for patients and providers and in creation of culturally informed 
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decision aids and manuals. The concept of shared decision making is not a new one, however, 
we are experiencing a paradigm shift with more emphasis in self-directed care in the mental 
health system. Both providers and patients want to share in medical decision making, but neither 
may be completely certain how to appropriately engage in collaborative exchange. This may be 
especially true for providers and their patients who have recently been discharged from an 
inpatient setting. Using culturally congruent decision aids and increasing patient activation and 
self-efficacy in making medical decisions may be viable methods of engaging individuals in 
care, thereby increasing collaborative decision-making. SDM has been demonstrated to improve 
outcomes for people across many areas of mental and physical health and must be implemented 
with thoughtful consideration of patients to realize its full potential. More research is needed as 
this is the first published attempt we are aware of to examine these demographic, clinical and 
communication variables within this population. 
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Table 1.1 Demographic characteristics and SDM collapsed control preference category 
(N=257) 
Characteristic N % 
Race or ethnicity   
Non-Hispanic White 99 38.4 
Hispanic 129 50.0 
African American 21 8.3 
Other/Mixed 5 1.9 
Unknown* 3 1.1 
Male 117 45.35% 
Diagnosis 
 
 
Major Depressive D/O 102 39.7 
Bipolar Disorder 78 30.3 
Unspecified Mood D/O 42 16.3 
Schizophrenia & Related D/O 35 13.6 
Age (M±SD years) (range 18-66) 37.95 11.9 
Collapsed SDM preference category   
Active 67 26.1% 
Collaborative 137 53.3% 
Passive 53 20.6% 
*Note: Data not captured at first visit and patient did not return to clinic, so data remains unknown 
Table 1.2 Breakdown of SDM preferences by race/ethnicity (N=257) 
Race/Ethnicity Active N (%) Collaborative N (%) Passive N (%) 
Non-Hispanic white 27 (27.3) 58 (58.6) 14 (14.1) 
Hispanic 26 (20.2) 67 (51.9) 36 (27.9) 
African American 9 (42.9) 9 (42.9) 3 (14.3) 
Other/Mixed 4 (1.6)* 1 (0.4) 0 (0.0) 
Unknown 1 (0.4) 2 (0.8) 0 (0.0) 
*Note: There is a possibility these 4 patients are a mix of African American, thereby increasing the overall 
likelihood of African Americans choosing a more active role in decision-making. 
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Abstract  
 
There is increased interest over the last decade in the use of Shared Decision Making with 
individuals with serious mental illness to improve engagement in treatment and patient 
outcomes. We conducted semi-structured qualitative interviews with 15 individuals with serious 
mental illness treated in an outpatient transitional care clinic serving people immediately after 
discharge from a psychiatric hospitalization. Parallel interviews were conducted with a variety of 
clinical providers (n = 9).  Using latent thematic analysis six themes were identified including: 1) 
Differences in the Use of SDM, 2) Consideration of Past Experiences, 3) Decisional Power 
Preferences, 4) Use of SDM in Psychiatry Versus Other Areas of Medicine, 5) Dignity and 
Disengagement, and 6) External Forces Impacting SDM. Implications for clinical practice and 
research using a shared decision-making approach within this treatment setting are further 
discussed. 
 
Keywords: Severe mental illness, serious mental illness, shared decision making, transitional 
care clinic, mental health 
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Introduction 
Engagement in mental health services following psychiatric hospitalization is of critical 
importance for improving the lives of individuals with severe mental illness and reducing long 
term negative outcomes, such as hospitalization, homelessness and suicide (Velligan, 2009; Pasic 
et al, 2005). Patients who feel they are playing an active role in their treatment typically have 
better engagement and outcomes than patients who experience themselves as passive recipients 
of care (Alegrai, et al, 2014; Stewart, 2001). Although various intervention approaches have 
been used to increase engagement in outpatient treatment in serious mental illness (Roberts, 
2011), most methods do not emphasize the importance of patients participating in their own 
treatment decisions. Shared Decision Making (SDM) is an exception. SDM is a structured 
approach to communication in medicine that frames the interaction as a negotiation between 
mutual experts (patient and provider) and stresses the balanced use of empirical information and 
patient preferences and values in decision making (Charles, 1997).  SDM is compatible with 
evidence-based medicine in its emphasis on the use of empirical information to make treatment 
decisions (Guyatt, 2001), and with the serious mental illness consumer recovery movement in its 
emphasis on patient-centered care (Drake, 2010). Furthermore, the process of recovery from 
mental health conditions depends on patients taking personal accountability for medical 
decisions, including those about medications and types of therapies.  
 
SDM is well operationalized, with specific components and clinician competencies detailed in 
the literature (Campbell, 2007; Elwyn, 2005). Several of the fundamental SDM principles aim to 
help the individual in treatment become more aware a medical decision is needed, offer more 
than one option from which to choose, communicate the pros and cons of the different options 
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and support the patient to make informed choices (Sepucha et al, 2010). A shared decision-
making method recognizes the expertise gleaned from both providers and patients in making a 
joint decision. Additionally, research trials demonstrate interventions involving SDM are feasible 
and well tolerated by individuals with serious mental illness (Deegan, 2006; Hamman, 2011).  
 
Barriers to SDM Implementation and Dissemination with Serious Mental Illness 
Despite the apparent promise of SDM, there is a low level of adoption and implementation of 
this practice within the delivery of mental health care, relative to other areas of medicine 
(Pollard, 2015; De las Cuevas et al, 2013; Drake et al, 2010; Hamann et al, 2006).  Whether in 
physical medicine or mental health, efforts to increase patient involvement in decisions about 
their care face barriers such as overworked physicians, insufficient provider training, deficient 
medical information systems and physician time constraints (Legare, 2008; Towle, 2006). 
Specific to psychiatry, further complexity is introduced with the potential lack of applicability of 
SDM due to patient characteristics and inappropriate clinical situations (Solbjør et al, 2013). 
From the standpoint of efficiency, when SDM is used in prescriber-patient interactions, visits are 
perceived by prescribers to take more time than does a standard psychiatry appointment (Burton, 
2010) and doctors cite this as one factor that limits their use of SDM (Legare, 2008).   
 
Despite a desire to know more about their diagnosis, treatment options and side effects (Hamann 
et al, 2007; Drake et al, 2010), patients receiving psychiatric care report that prescribers often do 
not provide sufficient information or explain it in an understandable manner (Lorem et al, 2013; 
Garfield, 2004).  Attitudes about the use of SDM have been found to differ by profession, with 
physicians being more likely than occupational therapists and pharmacists to communicate about 
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the pros and cons of medical issues (Chong et al, 2013b).  At the patient level, difficulties in 
using SDM may be due in part to illness-related information processing challenges of the 
individual in treatment (Mahone, 2011; Hamann et al, 2011; Chong et al, 2013; McCabe et al, 
2013), suggesting the need for the use of decision support aids and other scaffolding techniques 
to aid patient preferences in decisions about their care (Deegan, 2006) that may be different from 
those used for non-mental health patients.  
 
Facilitators of SDM Implementation and Dissemination in Serious Mental Illness 
Evidence supports the use of SDM for individuals with serious mental illness (Hamman, 2011; 
Drake, 2010; Deegan, 2006).  Research on SDM in psychiatry has received support through the 
President’s New Freedom Commission (PNFC) on Mental Health and other important 
government policy reports supporting the notion that transformation of the mental health service 
delivery system to promote recovery hinges on treatments that give individuals real and 
meaningful choices about treatment options (President’s New Freedom Commission, 2003; 
Institute of Medicine, 2001). SDM may be of particular benefit in serious mental illness because 
of the high incidence of patient non-adherence with treatment due to factors including 
dissatisfaction with side effects from antipsychotic and mood stabilizing medications, poor 
insight into illness and functional and motivational challenges. For individuals who decline to 
take medications, SDM may constitute a reasonable approach to remaining engaged with care 
providers allowing them to take advantage of treatment options such as case management or 
psychotherapy, while continually re-evaluating the potential role of medication. For patients with 
poor insight or functional challenges, SDM represents a non-threatening approach to clarifying 
motivations and options for improving quality of life. Despite evidence of cognitive challenges 
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and problems with insight, there is evidence that adults with serious mental illness frequently 
make competent and prudent decisions (MacDonald et al, 2017).  For example, in studies of 
decisional capacity, individuals with schizophrenia (Carpenter et al, 2000) and severe depression 
(Lapid et al, 2003) performed as well as their non ill counterparts on measures of ability to 
provide informed consent following an educational intervention (Carpenter et al, 2000). 
Additionally, the Institute of Medicine (IOM) rebutted the belief that this group of individuals 
should be assumed to have impairment in decisional capacity when stating, “many people with 
mental illness, indeed, many with severe mental illnesses, are not incompetent on most measures 
of competency” (IOM, 2006, p. 112).  Despite frequent behavioral passivity, patients with 
serious mental illness express a strong desire to be informed about their illness and treatment 
options, and to be active participants in their treatment decisions (Velligan et al, 2017; Adams, 
2007; Arora, 2000; De las Cuevas, 2013). Similarly, mental health providers report positive 
attitudes toward SDM (Seale et al, 2006; Hamann et al, 2009). 
 
Despite promising data on the use of SDM, the uptake of this practice is poor within services 
provided to the seriously mentally ill population (Pollard, 2015; De las Cuevas et al, 2013; Drake 
et al, 2010; Hamann et al, 2006). The aim of this study was to identify the factors influencing the 
use of a shared decision-making model in a transitional care clinic providing treatment to 
individuals with serious mental illness after a psychiatric crisis or hospitalization.   
 
Methods 
Design 
We conducted one-on-one explorative interviews with individuals in treatment and a variety of 
74 
 
clinical providers. Fifteen patients and nine providers participated in one-on-one interviews 
describing their experiences with medical decision making in at the Transitional Care Clinic and 
in comparison to previous treatment settings.  Topics addressed during patient interviews 
included experiences with prescriber interactions and impact of the SDM process on medication 
visit outcomes and recovery. Providers discussed experiences using SDM as a practice in general 
and, specifically about feasibility and utility for individuals seeking care at the Transitional Care 
Clinic. The interviewer followed a semi-structured interview guide starting with broader 
questions and ending with more focused discussions on specific topics. 
 
Setting and Sample 
The study site was a Transitional Care Clinic funded by area hospitals, charitable organizations 
and an 1115 Medicaid Waiver. The clinic provides a wide range of services including medication 
management, evidence-based psychotherapy and case management for individuals with severe 
mental illness recently discharged or deferred from a psychiatric hospital or crisis setting. Severe 
mental illness is defined as a DSM-5 primary diagnosis of schizophrenia, schizoaffective 
disorder, bipolar disorder (with and without psychotic features), depression (with and without 
psychotic features), unspecified psychosis and unspecified mood disorder.  As part of an 
engagement-focused research study conducted from 2014 and 2016 at the Transitional Care 
Clinic (Patient-Centered Outcomes Research Institute [PCORI]; Contract number: IH-1304-
6506), all clinic providers were trained in SDM and continue to be trained in this modality. 
Provider participants were recruited via email from the first author requesting participation in the 
study. The nine participating providers included three psychiatrists, one nurse practitioner, one 
nurse, two psychologists (also served as clinic administrators) and two therapists. Patient 
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participants were recruited during regular medication clinic visits on two separate days in 
September, 2019. Individuals presenting at the clinic were asked by clinic staff about their 
interest in participating. All patients had capacity to provide consent. Interviews for patient and 
provider participants were conducted by the first author and lasted approximately 20-40 minutes. 
All interviews were conducted at the clinic and patient participants were paid $30 for their time.   
 
Data Collection 
Demographics were obtained from the patients and provider participants including age, gender 
and ethnicity. The semi-structured interview was developed by the authors (NM and DV) in 
collaboration with experts in the Department of Psychiatry and Behavioral Medicine, and the 
stakeholder advisory board of the Transitional Care Clinic.  Topics addressed included the 
patients’ experiences and satisfaction with prescriber interaction, impact of the SDM process on 
medication visit outcomes and comparisons to previous healthcare experiences.  The provider 
interview guide consisted of questions about experiences using SDM as a practice within the 
Transitional Care Clinic, including feasibility, and utility. The interview guide began with broad 
items to allow the participant to begin thinking about their experiences with SDM, what this 
method entails, their role in the decision-making process, and the information needed to make 
this approach successful. The interview then moved on to questions regarding how SDM affects 
participation in sessions and the impact on outcomes and recovery. All questions were open-
ended. For patient participants who displayed distractibility or difficulty understanding, 
questions were reworded or repeated. After conducting the fifteen patient and nine provider 
interviews, it was apparent that similar themes were discussed, and no new themes were 
emerging. Therefore, saturation was deemed to be reached and no further interviews were 
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conducted.  The research study was approved by both the University of Texas Health Science 
Center at Houston Committee for the Protection of Human Subjects and the University of Texas 
Health Science Center at San Antonio Institutional Review Board. 
 
Data Analysis 
Interviews were audio recorded and transcribed by research staff and were coded by two authors 
(NM and DV). Latent thematic analysis was used to analyze this exploratory data (Braun & 
Clarke, 2006)) and NVivo 12 software was used to organize the data (NVivo 12, QSR 
International Pty Ltd, 2018). Each participating group (patient and provider) was analyzed 
independently and then the group data were combined. Using inductive category development, 
the codes from all transcripts were thematically clustered to serve as the basis for higher level 
categories, of which there were 12. Inductive categorization allowed for coding the data without 
trying to fit it into a pre-existing coding frame, or the researcher’s analytic preconceptions 
(Braun & Clarke, 2006). This flexible method is used to identify patterns of meaning within data 
among participants and is not allied to any particular framework. We looked for themes 
especially relevant to differences in experiences of and preferences for SDM (e.g. desired 
balance of power); satisfaction with provider visits, including length of visits; how previous 
experiences affect current desire for and use of SDM; and consequences of not using an SDM 
approach. All codes were then grouped into these categories by the two researchers. Following 
thematic latent analysis (Braun & Clarke, 2006), the 12 semantic categories were further 
analyzed at the latent level to identify higher order themes, of which there were six. Any areas of 
disagreement were resolved by discussion until consensus was reached.  
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Results 
Sample Characteristics 
Of the patient participants, ten were female, four male and one nonbinary. Eight were white 
Hispanic, six were white non-Hispanic and one was African American. Participant 
characteristics can be seen in Table 2.1. Analysis of patient and provider interviews resulted in 
six major themes: 1) Differences in the Use of SDM, 2) Consideration of Past Experiences, 3) 
Decisional Power Preferences, 4) Use of SDM in Psychiatry Versus Other Areas of Medicine, 5) 
Dignity and Disengagement, and 6) External Forces Impacting SDM.    
 
Six Themes 
A number of important themes emerged from the research. Exemplary quotes from each theme 
can be viewed in Table 2.2.  
 
Differences in the Use of SDM 
A primary reason in attending appointments at the Transitional Care Clinic is to receive 
medication for mental health conditions, although many other treatments may be provided in 
addition to medication management. Specific to discussions of medication, the majority of 
comments from both patients and providers support the active provision of options including, 
research data, weighing pros and cons, and collaborative communication. Discussions around 
medication occur in most medication follow-up visits, even if no changes are needed or made. 
One patient participant recalled wanting an increase in medication, but that request was not 
fulfilled. However, a joint discussion still transpired. Prescribers typically offered options each 
time a medication or therapy was not satisfactory to the patient, whether due to side effects, 
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potency, or other reasons, and patients were pleased with this communication method. Providers 
and patients concur that the final decision on taking medication and deciding which medication 
to take is the responsibility of the patient, although the clinical provider is heavily relied upon for 
their expert knowledge. The respect given to provider knowledge was apparent from the vast 
majority of patient participants (12/15). Three patients described the experience of not feeling 
like a partner in decision making at the Transitional Care Clinic, recounting a lack of perceived 
power and an absence of a give-and-take conversation around treatment. All interviewed 
providers endorsed seeking to use a SDM approach, although none endorsed explaining the 
actual concept or methodology of SDM with patients. Decision aids (media or methods that 
inform patients about treatment options) are not regularly used by any interviewed providers to 
assist patients in making decisions, and only three patient participants endorsed a positive 
attitude about their potential use in mental healthcare.  
 
Consideration of Past Experiences  
All patient participants discussed experiencing any number of severe symptoms, such as 
psychotic episodes, debilitating depression, attempts at self-harm, and brief or long-term 
hospitalizations. Many (11/15) described previous negative experiences during psychiatric 
hospitalizations where they perceived having no input on anything, for example, daily schedule, 
medications taken and discharge date. These experiences created a perception of having no 
power in these situations. Similarly, providers discuss creating a “disempowered” group of 
patients because of these types of negative inpatient experiences. Providers further explained 
these negative, and often traumatic, experiences with no opportunity for input or perceived 
control shaped how patients believe they may or may not participate in their healthcare 
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management. They also refer to health disparities often present in the severely mentally ill 
population, including economic disadvantage, lack of access to healthcare and lower levels of 
education, as being interrelated to patients’ perceptions and understanding of mental healthcare.  
Providers acknowledged patients may not “know how to ask to be an equal partner” in their 
mental health treatment because they have essentially been trained not to do so. Comparably, 
providers also discussed differences in their own education and background influencing their 
beliefs about a SDM approach to care. There is a difference of opinion amongst providers as to 
the extent to which SDM is taught to mental health professionals during their formal education. 
The collaboration is more required for some job roles and providers acknowledged the use or 
uptake of a SDM approach may be generational, in that more newly trained providers may have 
received more education on this communication method.  
 
Decisional Power Preferences 
Both groups of participants agreed the patient and provider should share decision-making 
responsibility and many patients cited “50/50” as the appropriate balance of decision-making 
accountability. Most providers conveyed the patient should have more than 50% of the 
decisional authority (i.e. 60/40, 75/25), although two stated the situations and decisions varied 
too much to approximate a percentage. Two providers also introduced the importance of 
significant others in the patients’ lives, such as family members, who are part of the onus to 
providing input for health-related decisions. While most patient participants prefer nearer to an 
equal partnership, a small number (3 of 15) preferred to concede power to the provider. These 
three were all white Hispanic females.  
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Use of SDM in Psychiatry Versus Other Areas of Medicine 
The use of SDM in psychiatry was viewed as more important than its use in non-mental health 
settings. Providers often cited the lack of a specific test or scan to diagnose and treat ailments. 
“We don’t have an x-ray machine.” In these situations, patients participating as their own expert 
is of increased value. Patients described the importance of sharing in decisions as the precursor 
to a trusting relationship that fosters honesty and recovery. Several patients said they can talk to 
their current provider about topics they have never discussed previously with other providers--for 
example, repeated childhood trauma. This aligns with providers’ reports that sharing information 
is the best way to proceed with appropriate treatment options. The information on how someone 
is feeling what they have experienced informs the process of how physicians and therapists make 
treatment decisions. Providers mention pre-established guidelines for medication and therapies 
based on their knowledge of the case. If patients do not provide accurate or honest information, 
providers cannot put those protocols into action.  In physical medicine, there is often a clearly 
superior treatment option, for instance in cancer treatment, but this is typically not the case in 
mental health treatment—thus increasing the reliance on patient involvement. Providers and 
patients agree it may take more time upfront to engage in discussions that are essential to a SDM 
approach, but all reported this communication practice saves time later. For example, providers 
mentioned that extra time spent on discussions within the office may help reduce: 1) extra phone 
calls to clinic staff because details were omitted, 2) symptom recurrence and possible 
hospitalization, and 3) patient’s experience of unexpected side effects. Likewise, providers did 
not believe using a SDM approach uses more resources over the course of treatment. Several 
providers mentioned a higher likelihood of patients showing up to appointments as a potential 
cost saving aspect of using SDM.  
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Dignity and Disengagement 
Almost half of the interviewed patients (7/15) describe times, either in this clinic or in previous 
experiences, where they did not feel their opinions were taken into consideration and stopped 
seeking treatment or taking medication altogether. Patients described specific times where they 
requested a change in medication or other treatment and the provider did not consider their 
request; there was no attempt at discussion. These patients describe stopping all treatment, which 
led some to an increase in symptoms, suicide attempts and hospitalization. Patients and providers 
agree it is better to taper off of a medication or other treatment while remaining engaged with 
care providers. Possible consequences of not allowing patient input is their disengagement from 
the mental health system, self-harm, rehospitalization, or other negative outcomes. While 
decisions are sometimes made for individuals in treatment, many (10/15) described being their 
own expert and believe their personal knowledge must be considered, even if not pursued. There 
is a dignity in risk. While patients understand there may be negative consequences to reducing or 
stopping treatment, they want partnership in attaining their health goals, sometimes in opposition 
of what the providers believes is best practice 
 
External Forces Impacting SDM 
The majority of patients and provider participants support the notion of SDM and its use with 
individuals in a psychiatric setting. However, almost all indicated times when a more 
paternalistic approach is needed. The need for an authoritative style was linked to recurrent or 
worsening symptoms or fear for patient safety, including intent of suicide or homicide. All 
providers and all but one patient agreed the clinical provider, often the physician, carries the 
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weight of making decisions for the patient when their decisional capacity is impaired due to an 
“acute exacerbation of symptoms.” Likewise, providers exert a responsibility to their own 
clinical licenses and training that may be in opposition to what patients want.  Most providers 
listed following clinic (or systemic) rules as a responsibility (i.e., adhering to a rule restricting 
the prescribing of benzodiazepines) that may negatively impact the provider-patient relationship 
because the decision is out of their hands. Providers and patients agreed a discussion can still 
transpire that can minimize the negative feelings associated with not having a full or real choice. 
 
Discussion 
This is the first evaluation of the perceptions and preferences of individuals with serious mental 
illness and their providers regarding SDM in a clinic serving a population immediately following 
a psychiatric crisis or hospitalization. Results of this qualitative study suggest that patients and 
providers value SDM, understand its application, and believe it is related to better outcomes. 
Several important topics are evident and can inform future clinical care and research in this field.  
 
Implications for Clinical Practice 
The study supports the need to ensure that SDM is a routine practice in psychiatric care. Study 
participants made comments which are supported by research suggesting that a continued 
paternalistic approach in medical decision making continues to socialize individuals into the role 
of patient rather than equal partner (Murjic et al, 2015). Patients and providers identified 
potential serious consequences including, disengagement and abruptly terminating treatment, 
when patients do not participate in decisions and do not feel heard. Studies of SDM link 
increased patient involvement to improved treatment adherence and quality of life, while lack of 
patient involvement is related to lower adherence to treatment, patient satisfaction, and overall 
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health outcomes (Sepucha & Mulley, 2009). The reports that SDM improved show rates and 
reduced calls in between appointments is important to patients, providers and the agencies for 
which they work. Research continually demonstrates no shows increase overall healthcare costs 
and reduce the gains made from treatment (Kheirhah et al, 2016, Berg et al, 2013).  
 
Both patients and providers in this study assert that trust in the clinical provider and patient 
honesty is strengthened by the use of SDM. Patients are more likely to share personal 
information needed to inform treatment options. Research supports that a trusting relationship 
with a clinical provider can strengthen alliance and prevent crises or other serious negative 
outcomes (Arnow & Steidtmann, 2014; Howgego et al, 2003).  To improve partnerships, clinical 
providers can offer options and have a conversation, even when yielding to the patient’s request 
is not feasible.  As part of this conversation, providers must consider there is a certain dignity in 
risk-taking, even when not medically supported (i.e. getting off medication). Providers can state 
the pros and cons of certain decisions, but the final decision is the patients, assuming decisional 
capacity is intact.  Although there is less of an emphasis of SDM in mental health care (Pollard, 
2015; De las Cuevas et al, 2013; Drake et al, 2010; Hamann et al, 2006), the findings of this 
study suggest the use of a SDM approach is more important in this filed compared to traditional 
somatic care. Psychiatric care is dependent on the nature of communication and this is 
instrumental in whether care is deemed effective. When you do not have a clearly superlative 
treatment, often the case in psychiatry, the reliance on SDM becomes more important (Morant et 
al, 2016). As mental health treatment increasingly reaches toward a recovery-oriented system of 
care, Barry & Edgman-Levitan argue that SDM is the highest form of patient-centered care.  
 
Implications for Research 
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There is a need for more effectiveness studies on the influence of training in SDM practices for 
both patients and providers. Patients may benefit from learning about the methodology of SDM 
to level the playing field. That is, more explicitly explaining the concept, what it means, the 
benefits and the responsibilities involved. Likewise, in the increasingly diversified field of 
healthcare, practitioners enter their jobs with differing amounts of education on SDM practices. 
The effect of attempts to improve providers’ knowledge on this practice and implementation of 
SDM within the healthcare field remains insufficient (Legare et al, 2018). Implementation 
science research on the uptake of SDM strategies into organizational culture and climate is 
needed. Additionally, investigation of racial and ethnic differences in decision-making 
preferences can better inform clinical providers on how to individualize communication on 
decisional authority. While this study has too small a sample to draw conclusions on 
demographic information, the tendency for white Hispanic females to cede their autonomy needs 
further investigation. In somatic medicine, most interventional research on SDM has focused on 
decision aids to help patients build their preferences or to facilitate any kind of patient 
engagement (O’Connor et al, 2011) with far fewer attempts in the use of this strategy in mental 
health (Drake et al, 2010). The use of decision aids was not endorsed in this study but may be 
important in empowering patients to make more independent and informed choices.  
 
While many important themes and implications for future work were found from this research, 
several limitations are present. All interviews were performed in one clinic with individuals who 
spoke English. Interviewing patients and providers in different areas and those who speak other 
languages may have extended the variability of responses. Only one of 24 total participants were 
African American limiting the generalizability of these findings. Additionally, the concept of 
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SDM was new to several of the patient participants and it is possible that our explanations 
influenced their answers. 
 
In conclusion, shared decision making was viewed positively by all providers and most patients, 
although there is a wide range of opinions in the amount of power either person should have in 
medical decision making. Some patients are more likely to cede their control to the provider, 
resulting in the need for providers to adapt their approach to presenting information and eliciting 
patient engagement. Trust and honest communication is foundational to improved patient 
outcome and shared decision making is a tool to foster necessary engagement.  
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Table 2.1  Participant Characteristics 
 
  Patients (n = 15) Providers (n = 9) 
Age M = 41.2 (SD = xx) M = 48.9 (SD = 9.1) 
Gender 4 m, 10 f, 1 nb 4 m, 5 f 
Ethnicity white Hispanic (8) white Hispanic (4)  
  white non-Hispanic (6) non-Hispanic white (5) 
  African American (1) African American (0)  
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Table 2.2. Exemplary Quotes from Six Themes 
 
Differences in the Use of SDM 
“Yeah, we’ll talk about it, and then he’ll tell me about other medications, and then we pretty much kind of make the 
decision together.” patient 
“Well, I was doing good and everything, but all of a sudden, I started getting itches, and I just started feeling weird 
and stuff, so I was like, ‘Okay, it’s not for me. I don’t think this one’s working, doc.’ And he’s like, ‘Okay. We’ll try 
something else.’” patient 
“I’ve been tempted. Real tempted [to stop all medication]. But the doctor here also says ‘It’s your choice.’ And 
that’s a real shared decision in saying he doesn’t think it’s a great idea. He really don’t…But, he still let’s me make 
the final decision.”  patient 
“I’ve had a lot of really good luck with collaborative decision making in this office.” patient 
“But he’s just very determined. If he decides something that’s what it is. He has a lot more power. There’s no 
partnership.” patient 
“The goal is for them [patients] to be equal partners without any power differential or hierarchy.” provider 
“By discussing the available and data driven treatments with the advantages and disadvantages for each treatment, it 
allows the client to be informed of their options for treatment and allows them the opportunity to give input on how 
they want to be treated?” provider 
Consideration of Past Experiences 
“I was detained for, I felt for being honest… I told her exactly how I felt…and I ended up being detained and 
hospitalized. And I’m like, Well, the hell with this. I’m not gonna talk to these people ever again.” patient 
“It’s terrible. They don’t even care. They just give you these prescriptions, thank you, bye-bye.” patient 
“I’ve been here a while and it’s not fun, changing from one doctor and starting over. And I don’t want to do that, 
but I do want my doctor to understand me. I want to because the feeling of a panic attack is horrible. He [the doctor] 
doesn’t listen.”  patient 
“It didn’t start off well. I was very angry. I was angry with the cops, I was angry with everybody and angry when I 
came in here. I came into the clinic very angry and did not want to be here. It was a forced situation. patient 
“A lot of them [patients] said we didn’t know this was something that we should do because for so long we were 
told that we were unable to make decisions.” provider 
“Hearing the patient’s point of view really opened my eyes to how they were disempowered and how all the control 
was essentially put on someone else in their past.” provider 
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“I’ve seen patients surprised and really engaged in thinking about stuff that they weren’t expecting to be thinking 
about.” provider 
“A lot of them shied away from having input and a lot of them said that’s not my place. I should never tell a doctor 
what to do.” provider 
“Learning SDM practices takes time and practice for those who were trained to be more paternalistic.” provider 
Decisional Power Preferences 
“I think it should be a mix of both…Because you know what’s best for yourself, and then, well, the doc knows 
what’s best for you medically through her license. So I think it should be both. It’s a good thing. There’s a balance 
there.” patient 
“No – I don’t think so. I guess because of what did happen to me and that caused me to be here…I think it should 
still be both because if it was more one-sided – I don’t know how that would work because that’s giving more power 
to the other person over your life. I think it should still be discussed by both parties equally.” patient 
“The doctor should have slightly more because he’s the book smart. He’s done all the education to be the doctor.” 
patient 
“…because I say of course he knows better than me. I’m gonna say this and that. Who am I? I’m just there, so I 
come here for the help, you know. And that’s it.” patient 
“We should have less than 50%, unless the patient is exhibiting problems with decisional capacity at that time.” 
provider 
“It may be something like the patient has 65%, doctor has maybe 25%, and then other has 10%, which could include 
people like family members.” provider 
Use of SDM in Psychiatry Versus Other Areas of Medicine 
“It [SDM approach] helps a lot because I never talked about my past traumas before.” patient 
“It helps build a trust and respect. I’m not like a paycheck or salary. I respect them [providers] more because they 
show respect to me.” patient 
“It [SDM] offered me an opportunity to assess where I was headed and choose if I wanted to return to the path that 
I’d already set out for myself, or veer off on another course.” patient 
“It [SDM] makes patients want to participate in the process and feel engaged in the process. So I think it probably 
increased appointment adherence and prescribed treatments, which results in improved outcomes.” provider 
“The prescriber has the opportunity to build trust with the patient through the SDM process. When the patient is 
informed about their treatment options, they are more inclined to engage in treatment.” provider 
Dignity and Disengagement 
“…with regards to medication, there was one time when I introduced the idea of going off medication and he 
[prescriber] was extremely opposed to the idea of me going off medication…I began experimenting with going off 
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the medication on my own rather than doing so in an observed environment. So I stopped wanting to come in for 
mental health treatment, which turned into its own snowball of bad feelings. And really hurt. Then when things 
became a big problem for me, I wasn’t in an environment where I could be assisted, and so by the time that I 
returned to that environment, it was an emergency situation.” patient 
“The doctors that I had seen, she pretty much just made the decision for me, whenever I was saying I wasn’t feeling 
good, or whatever, trying to decide what medication to take. She pretty much just made the decision. I don’t really 
like that clinic and I didn’t go back.” patient 
“You need to take me into consideration because I know my body.”  patient 
“Sometimes I wish that, whatever doctor that I’m at, I wish that they could just feel what I’m feeling for just a 
minute so they could just have a little taste of what I go through.” patient 
“I really deeply believe in the importance of patients feeling autonomous, feeling that they are the main person 
guiding their life.” provider 
External Forces Impacting SDM 
“Yes, when symptoms, like impulsivity make me forget the long-term goal.” patient 
“…there’s an ability for, kind of, a circumnavigation. Like if I’m starting to veer off course there’s a way of just 
circumventing that. I probably wouldn’t be going back to school in January if she hadn’t done that [made the 
decision].” patient 
 “Not in my experience. There is never a time when the doctor should have more say than the patient.” patient 
“If somebody is talking about self-harm…in those moments the doctor needs to step in, in a much more directive 
way.” provider 
“For example, I’ll have patients come in and say, ‘I want to do this.’ And I’ll say, Well, I don’t completely y agree 
with it, although there is no absolute contraindication. These are the risks associated with it. It’s important to me that 
you accept the risks.” provider 
“When there’s an absolute contraindication, then I say, ‘There’s an absolute contraindication to this and I won’t 
prescribe it.’” provider 
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OVERALL CONCLUSION 
 
This study contributed to the limited published literature on SDM within the mental 
health field. To our knowledge this is the first evaluation of the perceptions and preferences of 
individuals with serious mental illness and their providers regarding SDM in a clinic serving a 
population immediately following a psychiatric crisis or hospitalization. Race/ethnicity is an 
important factor when using a SDM approach. African American individuals were more likely to 
want to be active or collaborative contributors in the medical decision-making process likely 
linked to a complex history of race in the medical profession. Many disparities are reported in 
the area of mental health when comparing African Americans to whites, including higher levels 
of incorrect diagnoses, underrepresentation in research, less access to treatment, more severe 
symptom ratings, greater functional impairment once diagnosed, and significantly fewer African 
Americans seeking treatment (Cosh et al, 2017; Cook et al, 2007; Parker & Satkoske, 2012; 
Oluwoye et al, 2018).  Furthermore, Eliacin et al (2016) reports African Americans are less 
likely to be engaged in treatment and often perform more poorly on healthcare activities linked 
to patient engagement, such as communicating effectively with providers and participating in 
treatment decisions. To this end, active engagement and participation in mental health treatment 
may represent an important component in addressing many of these inequalities.  
 
In contrast to African Americans, Hispanic individuals were more likely to choose a 
passive role in decision-making or cede their autonomy in decisional control. From a historical 
perspective, Hispanic individuals tend to be respectful of authority and more likely to adhere to a 
perceived power gradient, making them more likely to cede decision making to a medical 
provider (Kemp & Rasbridge, 2004; Gudykunst, 2004). Research indicates Hispanics are more 
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deferential to authority figures, depending on acculturation, and are less likely to engage in 
mental health treatment than whites (Patel & Bakken, 2010).  For these reasons, Añez et al 
(2008) proposed the application of motivational interviewing principles to Latino cultural values 
and emphasizes the need to promote a client-centered and culturally congruent therapeutic 
environment to improve the connection to and participation of these individuals. Providers may 
also work to improve their Hispanic patients’ self-efficacy in making sound medical decisions by 
dividing tasks and offering feedback and reinforcement for each aspect of illness self-
management.  
 
It is evident that baseline decision-making preferences need to be considered when 
providing mental health care. Patients of all races/ethnicities need to be aided on how to engage 
in the process of SDM and providers need to ensure they communicate the importance of active 
and collaborative participation, even in situations that may be new for individuals in treatment. 
This may involve recognizing the patient’s knowledge, allowing sufficient time for participation 
or explaining the benefits of participating in treatment including improved health outcomes and 
better quality of life (Vahdat et al, 2014).  In line with the emerging paradigm of patient-centered 
care, culturally appropriate decision making needs to be emphasized.  
 
While race/ethnicity is an important consideration when using a shared decision-making 
approach, other demographic, clinical and communication characteristics were not predictive of 
control preference style in this context. It may be other factors are more important in determining 
the extent to which someone wants to contribute in psychiatric decision making. The participants 
in this study had in common a recent acute psychiatric hospitalization or crisis. Perhaps given 
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this often traumatic and stressful event, other characteristics, such as age, gender and symptom 
acuity become less important as related to shared decision-making preferences.  Other possible 
explanations not explored in this study include previous experiences in the mental health system, 
including hospitalizations and personality traits.  
 
The results of this study suggest that patients and providers value the SDM approach, 
understand its application, and believe it is related to better clinical outcomes. Several important 
topics are evident and can inform future clinical care and research in this field. Regarding 
implications for clinical practice, the study supports the need to ensure that SDM is a routine 
practice in psychiatric care. Patients and providers identified potential serious consequences 
including, disengagement and abruptly terminating treatment, when patients do not participate in 
decisions and do not feel heard. Studies of SDM connect increased patient involvement to 
improved treatment adherence and quality of life, while lack of patient involvement is related to 
lower adherence to treatment, patient satisfaction, and overall health outcomes (Sepucha & 
Mulley, 2009). The reports in this study that SDM improved show rates and reduced calls in 
between appointments is important to patients, providers and the agencies for which they work. 
Research continually demonstrates no shows increase overall healthcare costs and reduce the 
gains made from treatment (Kheirhah et al, 2016, Berg et al, 2013).  
 
Both patients and providers in this study assert that trust in the clinical provider and 
patient honesty is strengthened by the use of SDM. Patients are more likely to share personal 
information needed to inform treatment options. Research supports that a trusting relationship 
with a clinical provider can strengthen alliance and prevent crises or other serious negative 
99 
 
outcomes (Arnow & Steidtmann, 2014; Howgego et al, 2003).  To improve partnerships, clinical 
providers can offer options and have a conversation, even when yielding to the patient’s request 
is not feasible.  As part of this conversation, providers must consider there is a certain dignity in 
risk-taking, even when not medically supported (i.e. getting off medication).  Although there is 
less of an emphasis of SDM in mental health care (Pollard, 2015; De las Cuevas et al, 2013; 
Drake et al, 2010; Hamann et al, 2006), the findings of this study suggest the use of a SDM 
approach is more important in this field compared to traditional somatic care. Psychiatric care is 
dependent on the nature of communication and this is instrumental in whether care is deemed 
effective. When you do not have a clearly superlative treatment, often the case in psychiatry, the 
reliance on SDM becomes more important (Morant et al, 2016).  
 
Regarding implications for future research, there is a need for more effectiveness studies 
on the influence of training in SDM practices for both patients and providers. Patients may 
benefit from providers more explicitly explaining the concept of SDM, what it means, and the 
benefits and the responsibilities involved. Likewise, in the increasingly diversified field of 
healthcare, practitioners enter their jobs with differing amounts of education on SDM practices. 
The effect of attempts to improve providers’ knowledge on this practice and implementation of 
SDM within the healthcare field remains insufficient (Legare et al, 2018). Implementation 
science research on the uptake of SDM strategies into organizational culture and climate is 
needed. Additionally, investigation of racial and ethnic differences in decision-making 
preferences can better inform clinical providers on how to individualize communication on 
decisional authority.  
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There are several limitations to this study that should be noted. Multiple tests of statistical 
significance were utilized in the quantitative analyses and may have increased the likelihood that 
the relationship between race/ethnicity and control preference group was due to chance. The 
cross-sectional nature of this study did not allow for examination of difference in SDM styles 
over time and a relatively smaller percentage of African American study participants make it 
difficult to generalize from these results. The control preference groups were determined by one 
self-reported assessment. While the Control Preferences Scale is a validated instrument, it is 
possible that more sensitive scales or use of more than one scale is needed.  Additionally, all 
interviews were performed in one clinic with individuals who spoke English. Interviewing 
patients and providers in different geographic areas and those who speak other languages may 
have extended the variability of responses.  
 
Despite the limitations described above, the study highlighted that SDM preferences are 
different across individuals in this treatment setting. These preferences need to be considered in 
approaching SDM education for patients and providers and in creation of culturally informed 
decision aids and manuals. The concept of SDM is not a new one, however, we are experiencing 
a paradigm shift with more emphasis in self-directed care in the mental health system. Both 
providers and patients want to share in medical decision making, but neither may be completely 
certain how to appropriately engage in collaborative exchange. This may be especially true for 
providers and their patients who have recently been discharged from an inpatient setting. Using 
culturally congruent decision aids and increasing patient activation and self-efficacy in making 
medical decisions may be viable methods of engaging individuals in care, thereby increasing 
collaborative decision-making. SDM has been demonstrated to improve outcomes for people 
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across many areas of mental and physical health and must be implemented with thoughtful 
consideration of patients to realize its full potential.  
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Appendix A. Control Preferences Scale - Cards 
 
 
 
 
 
 
I PREFER TO MAKE THE FINAL SELECTION 
ABOUT WHICH TREATMENT I WILL RECEIVE. 
 
 
 
  
 
 
I PREFER TO MAKE THE FINAL SELECTION 
OF MY TREATMENT AFTER SERIOUSLY 
CONSIDERING MY DOCTOR’S OPINION. 
 
  
 
 
 
 
 
 
I PREFER THAT MY DOCTOR AND I 
SHARE RESPONSIBILITY FOR 
DECIDING WHICH TREATMENT IS 
BEST FOR ME. 
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I PREFER THAT MY DOCTOR MAKES THE 
FINAL DECISION ABOUT WHICH 
TREATMENT WILL BE USED, BUT 
SERIOUSLY CONSIDERS MY OPINION. 
 
   
 
 
 
 
I PREFER TO LEAVE ALL DECISIONS REGARDING 
MY TREATMENT TO MY DOCTOR. 
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Appendix B:  Control Preference Scale Score Sheet 
 
To score the completed scale, use the top 2 preferred cards to determine which category the 
patient falls into. 
 
Please circle the appropriate number for the top 2 cards: 
 
1 – Active-Active (card order AB or BA) – enter 1 in the data file 
 
 
2 – Active-Collaborative (card order BC) – enter 2 in the data file 
 
 
3 – Collaborative-Active (card order CB) – enter 3 in the data file 
 
 
4 – Collaborative-Passive (card order CD) – enter 4 in the data file 
 
 
5 – Passive-Collaborative (card order DC) – enter 5 in the data file 
 
 
6 – Passive-Passive (card order DE or ED) – enter 6 in the data file 
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Appendix C: Matched Pair Instrument (Provider) 
 
Using your opinion of today’s appointment, please rate each item using the 5-point scale provided. 
Circle your response. 
  
 
 
Not at 
all true 
Slightly 
true 
Moderately 
true 
Mostly 
true 
Very 
true 
1. Greeted the patient in a way 
that made them feel 
comfortable. 
0 1 2 3 4 
2. Discussed patient’s reason(s) 
for coming today. 
0 1 2 3 4 
3. Encouraged patient to express 
their thoughts concerning any 
health problems 
0 1 2 3 4 
4. Listened carefully to what they 
had to say. 
0 1 2 3 4 
5. Understood what they had to 
say. 
0 1 2 3 4 
6. If a physical exam or lab test 
was needed, explained what 
was done and why. 
0 1 2 3 4 
7. Discussed treatment options 
with them. 
0 1 2 3 4 
8. Gave the patient as much 
information as they wanted. 
0 1 2 3 4 
9. Checked with the patient to see 
if the treatment plan was 
acceptable. 
0 1 2 3 4 
10. Explained medications, if any, 
including possible side-effects. 
0 1 2 3 4 
11. Encouraged the patient to ask 
questions. 
0 1 2 3 4 
12. Responded to questions and 
concerns. 
0 1 2 3 4 
13. Involved the patient in 
decisions as much as he or she 
wanted. 
0 1 2 3 4 
14. Discussed next steps including 
any follow-up plans. 
0 1 2 3 4 
15. Checked to be sure the patient 
understood everything. 
0 1 2 3 4 
16. Showed care and concern 
about the patient as a person. 
0 1 2 3 4 
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17. Spent the right amount of time 
with them. 
0 1 2 3 4 
18. Overall, I was satisfied with 
this meeting today. 
0 1 2 3 4 
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Appendix D:  Matched Pair Instrument (Consumer) 
 
Using your opinion of today’s appointment, please rate each item using the 5-point scale provided. Circle 
your response. 
  
  
 
 
Not at 
all true 
Slightly 
true 
Moderately 
true 
Mostly 
true 
Very 
true 
1. Greeted me in a way that made 
me feel comfortable. 
0 1 2 3 4 
2. Discussed me reason(s) for 
coming today. 
0 1 2 3 4 
3. Encouraged me to express my 
thoughts concerning my health 
problems 
0 1 2 3 4 
4. Listened carefully to what I 
had to say. 
0 1 2 3 4 
5. Understood what I had to say. 0 1 2 3 4 
6. If a physical exam or lab test 
was needed, explained what 
was done and why. 
0 1 2 3 4 
7. Discussed treatment options 
with me. 
0 1 2 3 4 
8. Gave me as much information 
as I wanted. 
0 1 2 3 4 
9. Checked to see if the treatment 
plan was acceptable to me. 
0 1 2 3 4 
10. Explained medications, if any, 
including possible side-effects. 
0 1 2 3 4 
11. Encouraged me to ask 
questions. 
0 1 2 3 4 
12. Responded to my questions 
and concerns. 
0 1 2 3 4 
13. Involved me in decisions as 
much as I wanted. 
0 1 2 3 4 
14. Discussed next steps including 
any follow-up plans. 
0 1 2 3 4 
15. Checked to be sure I 
understood everything. 
0 1 2 3 4 
16. Showed care and concern 
about me as a person. 
0 1 2 3 4 
17. Spent the right amount of time 
with me. 
0 1 2 3 4 
18. Overall, I was satisfied with 
my visit to the doctor today. 
0 1 2 3 4 
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Appendix E: Brief Psychiatric Rating Scale (BPRS) 
 
Instructions:  This form consists of 24 symptom constructs, each to be rated on a 7-point scale 
of severity ranging from “not present” to “extremely severe”.  If a specific symptom is not rated, 
mark “NA”, Not Assessed.  Circle the number headed by the term that best describes the 
patient’s present condition. 
 
 NA            1          2           3  4  5    6 
 7 
Not Assessed     Not Present Very Mild    Mild   Moderate Moderately Severe      Severe  
 Extremely Severe 
 
Rate items 1-10 on the basis of patient’s self-report. 
1.   Somatic Concerns  NA       1       2       3       4       5       6       7  
2.   Anxiety   NA       1       2       3       4       5       6       7  
3.   Depression   NA       1       2       3       4       5       6       7  
4.   Guilt    NA       1       2       3       4       5       6       7  
5.   Hostility   NA       1       2       3       4       5       6       7  
6.  Suspiciousness  NA       1       2       3       4       5       6       7  
7.   Unusual Thought Content NA       1       2       3       4       5       6       7  
8.   Grandiosity   NA       1       2       3       4       5       6       7  
9.   Hallucinations  NA       1       2       3       4       5       6       7  
10.   Disorientation  NA       1       2       3       4       5       6       7  
 
Rate items 11-24 on the basis of observed behavior and speech 
11.   Conceptual Disorganization NA       1       2       3       4       5       6       7  
12.   Excitement   NA       1       2       3       4       5       6       7  
13.   Motor Retardation   NA       1       2       3       4       5       6       7  
14.   Blunted Affect  NA       1       2       3       4       5       6       7  
15.   Tension   NA       1       2       3       4       5       6       7  
16.   Mannerisms and Posturing NA       1       2       3       4       5       6       7  
17.   Uncooperativeness  NA       1       2       3       4       5       6       7  
18.   Emotional Withdrawal  NA       1       2       3       4       5       6       7  
19.   Suicidality    NA       1       2       3       4       5       6       7  
20.   Self-neglect    NA       1       2       3       4       5       6       7  
21.   Bizarre Behavior   NA       1       2       3       4       5       6       7  
22.   Elevated Mood  NA       1       2       3       4       5       6       7  
23.   Motor Hyperactivity  NA       1       2       3       4       5       6       7  
24.   Distractibility  NA       1       2       3       4       5       6       7  
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Appendix F:  BPRS Factors and Variables 
 
Psychosis—includes Suspiciousness, Unusual Thought Content, Hallucinations, and Conceptual 
Disorganization 
 
Depression—includes Anxiety, Depression, and Guilt 
 
Psychomotor Retardation—includes Motor Retardation, Blunted Affect, and Emotional 
Withdrawal 
 
Paranoia—includes Hostility, Suspiciousness, and Uncooperativeness 
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Appendix G:  Scale to Assess Unawareness of Mental Disorder (SUMD); (Abbreviated 
Version) 
 
1.  Awareness of mental disorder. 
In the most general terms, does the subject believe that s/he has a mental disorder, psychiatric 
problem, or emotional difficulty, etc.? 
 
0 Cannot be assessed 
1 Aware:  Subject clearly believes that s/he has a mental disorder 
2 
3 Somewhat:  Is unsure about whether s/he has a mental disorder but can entertain the idea that s/he 
might. 
4 
5 Unaware:  Believes s/he does not have a mental disorder 
                  
2.  Awareness of achieved effects of medication   
What is the subject’s belief regarding the effects of medication?  Does the subject believe that 
medications have lessened the intensity or frequency of his/her symptoms (i.e. if applicable)? 
 
0 Cannot be assessed 
1 Aware:  Subject clearly believes medications have lessened the intensity or frequency of his/her 
symptoms. 
2 
3 Somewhat:  Is unsure about whether medications have lessened the intensity or frequency of 
his/her symptoms, but can entertain the idea 
4 
5 Unaware:  Believes that medications have not lessened the intensity or frequency of his/her 
symptoms. 
   
3.  Awareness of social consequences of mental disorder 
 What is the subject’s belief regarding the reason s/he has been admitted to the hospital, involuntarily 
hospitalized, arrested, evicted, fired, injured, etc.? 
 
0 Cannot be assessed 
1 Aware:  Subject clearly believes that the relevant social consequences are related to having a 
mental disorder. 
2 
3 Somewhat:  Is unsure about whether the relevant social consequences are related to having a 
mental disorder. 
4 
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5 Unaware:  Believes that the relevant social consequences have nothing to do with having a mental 
disorder. 
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Appendix H. Qualitative Interview Guide - Staff 
Staff Interview Guide (Maples) 
INTERVIEW GUIDE 
  
Staff VERSION – Prescribers 
 
Study Objective Progression of Questions in Interview Guide  
OBJECTIVE:   
The overall objective of this study is to 
collect information from prescribers and 
other involved staff the use of shared 
decision making in the post-acute 
psychiatric treatment setting (transitional 
care clinic-TCC). The special focus of 
this interview is to understand staff 
experiences of shared decision making in 
general and the Shared Decision Making 
(SDM) intervention used at the 
Transitional Care Clinic. In addition, we 
would like to understand the impact of 
SDM on the relationship between 
patients and staff and the outcomes of the 
patient.   
Specific objectives are as follows:  
1. Identify and document thoughts 
about and experiences with 
shared decision making in general 
and using shared decision making 
in patient encounters. 
2. Clarify the importance of various 
aspects of SDM from the staff 
perspective including decision 
tools, web materials, patient 
videos and TAC-REVIEW. 
3. Identify barriers and facilitators to 
the use of SDM in the post-acute 
psychiatric clinic setting. 
4. Identify the impact of SDM on 
outcomes.  
 
OVERALL FLOW: 
Shared Decision Making: Open-ended 
exploration of SDM in general 
Specific questions about SDM  
 
Basic Understanding 
Experiences with SDM 
Thoughts about responsibility and involvement 
How much and what kind of information is 
appropriate to provide? 
 
Shared Decision Making intervention:  Open-
ended exploration of specific SDM thoughts and 
impressions of the intervention and its impact 
upon outcomes. 
  
Usefulness of coaches 
Impact on Timing and Length of psychiatric 
appointments  
Decision tools 
Web sites 
TAC-REVIEW 
Barriers to using the intervention: What got in 
the way of the processes of SDM or its 
application? 
 
Percieved limits to patient understanding 
Percieved limits of competence 
Limits of materials 
 
 
Impact on process and outcomes 
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INTERVIEWER INSTRUCTIONS 
 
Your goal as the interviewer is to elicit information on the topics of interest without influencing 
participant’s responses. To do this, begin each topic area with broad, open-ended questions, and 
then ask more specific questions to clarify and elicit more detail regarding participant’s 
responses. 
 
Begin each topic area by posing questions broadly. Specific wording for the interviewer is 
denoted in bold font. Follow with the more specific questions.  It is not necessary to explicitly 
ask each of the bulleted prompts within a topic area, but you should refer to the bullets to ensure 
that each topic is addressed with sufficient coverage, rather than focusing on just one or two 
narrow areas.  
 
INTERVIEW GUIDE  
 
TO BEGIN:    
1. Introduce yourself and your association with the study. 
2. Explain purpose of the interview. 
3. Thank participants for their willingness to participate. 
4. Assure the participant of confidentiality, including that this study will not impact 
employment at TCC, and that neither other the TCC providers nor the SDM coach will 
learn their answers. 
5. Let them know the general process of how it will proceed. 
 
 
The purpose of this interview: 
This interview will take approximately 30-45 minutes. I will ask you a variety of questions 
to help us better understand your experiences with shared decision making in general and 
how this process works with patients. I will ask about your overall impressions, how SDM 
impacts the timing and length of encounters, how the specific strategies used impact the 
visit, and what works or does not work for you in terms of helping the patient understand 
their options and communicating decisions. I will also ask your opinions about how the use 
of SDM impacts patient outcomes. 
 
How this interview will work:   
I will start by asking more general questions then become more specific. I am interested in 
what you have to say about your experiences, so please respond with whatever is on your 
mind. 
 
I want to remind you this interview is being recorded. I will not use your name from the 
point that I turn on the recorder, and I will ask you to try and not use your name or the 
names of specific patients or staff members in any of your responses. This will help keep 
the interview anonymous.   
I will use the recording only to remind me of the important things you said so we can use 
your input. The recordings will be transcribed, and then put together with transcripts from 
everyone else taking part in these interviews. All recordings will be deleted after they are 
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transcribed. You will not be individually identified in any of the reports that result from 
these interviews. I ask you for your honest opinion during this interview.  
Do you have any questions or concerns before we begin? 
 
INTERVIEW ITEMS 
 
 
I. FIRST DISCUSSION ITEM  
Purpose: Initial, broad item to get participant to begin thinking about their SDM experiences, 
what it entails, about their role in the process, and the information needed to make it work. 
 
To start, I’d like you to think about shared decision-making in encounters with patients, 
what it means and what you think about this approach to patient care. 
 
1. How do you understand shared decision making? 
2. In general, what do you think of the shared decision making approach? 
3. Do you ever explain shared decision making to patients? If yes, how? 
4. How much responsibility do you think you and other doctors should have in 
decisions about patient’s mental health treatment? 
5. Are there certain times when you want a lot of patient input into decision making? 
(Some examples) 
6. Are there certain times when you feel you want to be the primary decision maker 
about the patient’s psychiatric treatment? (Some examples)  
 
II. SECOND  DISCUSSION ITEM  
Purpose: This item is designed to get participants to begin thinking about the SDM training and 
use of the coach for patients at TCC specifically, what they thought and felt about it.  
 
Now I’d like you to think about your experiences with SDM training and with SDM 
coaching specifically at the Transitional Care Clinic. 
 
1. What did you learn in the training? Was this new information? 
2. What are some things you like or did not like about the patients participating in 
shared decision making coaching? 
3. What information do you think is needed from the SDM coach to help the patient 
improve their visit with you? 
4. How do you think SDM coaching impacts patient preparedness for visits with you? 
 
III. THIRD DISCUSSION ITEM  
Purpose: The purpose of this item is to get the participant discussing any barriers or facilitators 
they saw or experienced in the use of SDM in their clinic. 
At this point I’d like you to think about things that might make it easy or difficult for you 
to participate in a shared decision making approach to care at the Transitional Care Clinic. 
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(These can be mirror images of the questions above and may be unnecessary if they have already 
discussed.) 
1. What kind of problems do you have in using SDM? 
2. What are the difficulties in patients understanding SDM concepts?  
3. What are the difficulties in patients taking more responsibility in making medical 
decisions? 
4. What is most helpful about the SDM approach?  
5. What is least helpful? 
6. How did you feel about the length of sessions with patients when using the SDM 
model of care? (Did they get longer or take additional effort or resources due to 
using SDM?)  
7. Tell me about the costs of using an SDM approach. Do they outweigh the benefits? 
(Why?) 
8. What kinds of characteristics make it easier or more difficult for patients to engage 
in SDM? 
9. Thinking specifically about the use of SDM at the TCC, how do you feel about how 
easy or difficult it was to fit this model into your treatment practices? (Why?) 
10. Explain the benefits you personally receive in your work from using SDM, if any.  
11. There is a movement to integrated models of healthcare. How do you feel SDM fits 
within this public health priority? 
12. Are there any other problems or benefits in using SDM we have not yet talked 
about? 
 
IV. FOURTH DISCUSSION ITEM    
Purpose: More specific focus on how SDM changed their participation in sessions with the 
patient. 
Now let’s get a little more focused and talk about how much and in what ways SDM 
changed the way you interact with patients and vice versa. (These can be mirror images of 
the questions above and may not be unnecessary if they have already discussed.) 
1. Think of times you treated patients similar to those at the TCC prior to learning 
shared decision making. What differences do you find in your treatment now? 
2. What is different about your communication behavior with patients when using 
SDM? 
3. In what way does SDM impact the way you discuss a specific medication or 
treatment with patients?  
4. How do you think knowing SDM impacts how seriously you take patients’ input 
about medical decisions?   
5. What changes have you seen in patient’s communication to you as a result of 
adopting SDM?  
6. In using SDM, do you believe the patient feels like an equal partner in decisions 
about their treatment? (Explain) 
 
V. FIFTH DISCUSSION ITEM    
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Purpose: To gather information about how SDM impacted your outcomes  
Think about how SDM impacts patient outcomes. 
1. In what way do you believe SDM may help or hurt your patient’s recovery? 
2. In what way do you believe SDM may help or hurt your patient’s engagement in 
treatment?  
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Appendix H2. Qualitative Interview Guide - Staff  
 
Staff Interview Guide (Maples) 
INTERVIEW GUIDE 
  
Staff Version – Other Clinic Personnel 
 
Study Objective Progression of Questions in Interview Guide  
OBJECTIVE:   
The overall objective of this study is to 
collect information from prescribers and 
other involved staff the use of shared 
decision-making in the post-acute 
psychiatric treatment setting (transitional 
care clinic-TCC). The special focus of 
this interview is to understand staff 
experiences of shared decision making in 
general and the Shared Decision Making 
(SDM) intervention used at the 
Transitional Care Clinic. In addition, we 
would like to understand the impact of 
SDM on the relationship between 
patients and staff and the outcomes of the 
patient.   
Specific objectives are as follows:  
5. Identify and document thoughts 
about and experiences with 
shared decision making in general 
and using shared decision making 
in patient encounters. 
6. Clarify the importance of various 
aspects of SDM from the staff 
perspective including decision 
tools, web materials, patient 
videos and TAC-REVIEW. 
7. Identify barriers and facilitators to 
the use of SDM in the post-acute 
psychiatric clinic setting. 
8. Identify the impact of SDM on 
outcomes.  
 
OVERALL FLOW: 
Shared Decision Making: Open-ended 
exploration of SDM in general 
Specific questions about SDM  
 
Basic Understanding 
Experiences with SDM 
Thoughts about responsibility and involvement 
How much and what kind of information is 
appropriate to provide? 
 
Shared Decision Making intervention:  Open-
ended exploration of specific SDM thoughts and 
impressions of the intervention and its impact 
upon outcomes. 
  
Usefulness of coaches 
Impact on Timing and Length of psychiatric 
appointments  
Decision tools 
Web sites 
TAC-REVIEW 
Barriers to using the intervention: What got in 
the way of the processes of SDM or its 
application? 
 
Percieved limits to patient understanding 
Percieved limits of competence 
Limits of materials 
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Impact on process and outcomes 
 
 
 
INTERVIEWER INSTRUCTIONS 
 
Your goal as the interviewer is to elicit information on the topics of interest without influencing 
participant’s responses. To do this, begin each topic area with broad, open-ended questions, and 
then ask more specific questions to clarify and elicit more detail regarding participant’s 
responses. 
 
Begin each topic area by posing questions broadly. Specific wording for the interviewer is 
denoted in bold font. Follow with the more specific questions.  It is not necessary to explicitly 
ask each of the bulleted prompts within a topic area, but you should refer to the bullets to ensure 
that each topic is addressed with sufficient coverage, rather than focusing on just one or two 
narrow areas.  
 
INTERVIEW GUIDE  
 
TO BEGIN:    
6. Introduce yourself and your association with the study. 
7. Explain purpose of the interview. 
8. Thank participants for their willingness to participate. 
9. Assure the participant of confidentiality, including that this study will not impact 
employment at TCC, and that neither other the TCC providers nor the SDM coach will 
learn their answers. 
10. Let them know the general process of how it will proceed. 
 
 
The purpose of this interview: 
This interview will take approximately 45-60 minutes. I will ask you a variety of questions 
to help us better understand your experiences with shared decision making in general and 
how this process works with patients. I will ask about your overall impressions, how SDM 
impacts the timing and length of encounters, how the specific strategies used impact the 
visit, and what works or does not work for you in terms of helping the patient understand 
their options and communicating decisions. I will also ask your opinions about how the use 
of SDM impacts patient outcomes. 
 
How this interview will work:   
I will ask general questions, and after each one there will be some time for you to respond.  
We are interested in what you have to say about your experiences, so please respond with 
whatever is on your mind. 
 
I want to remind you this interview is being recorded. I will not use your name from the 
point that I turn on the recorder, and I will ask you to try and not use your name or the 
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names of specific patients or staff members in any of your responses. This will help keep 
the interview anonymous.   
I will use the recording only to remind me of the important things you said so we can use 
your input. The recordings will be transcribed, and then put together with transcripts from 
everyone else taking part in these interviews. All recordings will be deleted after they are 
transcribed. You will not be individually identified in any of the reports that result from 
these interviews. I ask you for your honest opinion during this interview.  
 
Do you have any questions before we start? 
 
 
 
INTERVIEW ITEMS 
 
VI. FIRST DISCUSSION ITEM  
Purpose: Initial, broad item to get participant to begin thinking about their SDM experiences, 
what it entails, about their role in the process, and the information needed to make it work. 
 
To start, I’d like you to think about shared decision-making in encounters with patients, 
what it means and what you think about this approach to patient care. 
 
7. How do you understand shared-decision making? 
8. How do you feel about someone helping the patient prepare for visits with their 
doctor and other members of the treatment team? 
9. In general, what do you think of the shared decision-making approach? 
10. How do you explain shared decision making to patients? 
11. How much responsibility do you think doctors should have in decisions about their 
patient’s mental health care? 
12. What are some examples of when you think the doctor should be the primary 
decision maker? 
13. What are some examples of when you think the patient should be the primary 
decision maker? 
 
VII. SECOND  DISCUSSION ITEM  
Purpose: This item is designed to get participants to begin thinking about the SDM training and 
use of the coach for patients at TCC specifically, what they thought and felt about it.  
 
Now I’d like you to think about your experiences with SDM training and with the SDM 
coach at the Transitional Care Clinic. 
 
5. What did you learn in the training? Was this new information? 
6. What are some things you like or do not like about having patients participate in the 
shared decision making meetings with a coach? 
7. What information do you think is needed from an SDM coach to help the patient 
improve their visit with the doctor? 
8. How do you think SDM coaching impacts patient preparedness for doctor’s visits? 
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VIII. THIRD DISCUSSION ITEM  
Purpose: The purpose of this item is to get the participant discussing any barriers or facilitators 
they saw or experienced in the use of SDM in their clinic. 
 
At this point I’d like you to think about things that might make it easy or difficult for you 
to participate in an SDM approach to care. (These can be mirror images of the questions 
above and may be unnecessary if they have already discussed.) 
13. What kind of problems do you have using SDM? 
14. What are the difficulties in patients understanding SDM concepts? 
15. What are the difficulties in patients taking more responsibility in making medical 
decisions? 
16. What is most helpful about the SDM approach?  
17. What is least helpful? 
18. How do you feel about addition of and length of the sessions for SDM coaching?  
19. Tell me about the costs of using an SDM approach. Do they outweigh the benefits? 
(Why?) 
20. What kinds of characteristics make it easier or more difficult for patients to engage 
in SDM? 
21. Thinking specifically about the use of SDM at the TCC, how do you feel about how 
easy or difficult it was to fit this model into clinic practices? (Why?) 
22. Explain the benefits you personally receive in your work from using SDM, if any.  
23. There is a movement to integrated models of healthcare. How do you feel SDM fits 
within this public health priority? 
24. Are there any other problems or benefits in using SDM that we have not yet talked 
about? 
 
IX. FOURTH DISCUSSION ITEM    
Purpose: More specific focus on how SDM changed their participation in sessions with the 
patient. 
 
Now let’s get a little more focused and talk about how much and in what ways SDM 
changed the way you interact with patients, and how they interact with you or other clinic 
staff. (These can be mirror images of the questions above and may be unnecessary if they have 
already discussed.) 
7. In what ways do you think SDM coaching changes the way patients try to work with 
their doctor in decision making? 
8. What is different about your communication behavior with patients when using 
SDM? 
9. How do you think knowing SDM impacts how seriously you take patients’ thoughts 
and concerns?   
10. What changes have you seen in patient’s communication to you or other clinic staff 
as a result of adopting SDM? 
11. Do you think the patient feels like an equal partner in decisions about their 
treatment? (Explain) 
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X. FIFTH DISCUSSION ITEM    
Purpose: To gather information about how SDM impacted your outcomes  
Think about how SDM impacts patient outcomes. 
3. In what way do you believe SDM may help or hurt patient recovery? 
4. In what way do you believe SDM may help or hurt patient engagement in 
treatment?  
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Appendix I: Qualitative Interview Questions – Patient Version 
 
Patient Interview Guide (Maples) 
INTERVIEW GUIDE 
  
PATIENT VERSION 
 
Study Objective Progression of Questions in Interview Guide  
OBJECTIVE:   
The overall objective of this study is to 
collect information from patients about 
their preferences in sharing decisions 
about their post-acute psychiatric 
treatment. The special focus of this 
interview is to understand patient desires 
and experiences of shared decision 
making in general and the Shared 
Decision Making (SDM) intervention 
used at the Transitional Care Clinic 
including the prescriber, SDM coach, 
specific techniques and available 
resources. In addition, we would like to 
understand the impact of SDM on the 
patient’s treatment and outcomes.   
Specific objectives are as follows:  
9. Identify and document patient 
thoughts about and experiences 
with shared decision making in 
general and responses to the 
shared decision making 
intervention. 
10. Clarify the importance of various 
aspects of SDM treatment 
including decision tools, web 
materials, patient videos and 
TAC-REVIEW. 
11. Identify barriers and facilitators to 
the use of SDM in the post-acute 
psychiatric clinic setting. 
12. Identify the impact of SDM on 
outcomes.  
 
OVERALL FLOW: 
Shared Decision Making: Open-ended 
exploration of SDM in general 
Specific questions about SDM  
 
Basic Understanding 
Experiences with SDM 
Thoughts about responsibility and involvement 
How much and what kind of information might 
be needed? 
 
Shared Decision Making intervention:  Open-
ended exploration of specific SDM thoughts and 
impressions of the intervention and its impact 
upon outcomes. 
  
Usefulness of coaches 
Timing and Length  
Decision tools 
Web sites 
TAC-REVIEW 
Barriers to using the intervention: What got in 
the way of the processes of SDM or its 
application? 
Limits of information 
Percieved limits to understanding 
Time and timing 
Limits of practitioners 
Limits of materials 
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INTERVIEWER INSTRUCTIONS 
 
Your goal as the interviewer is to elicit information on the topics of interest without influencing 
participant’s responses. To do this, begin each topic area with broad, open-ended questions, and 
then ask more specific questions to clarify and elicit more detail regarding participant’s 
responses. 
 
Begin each topic area by posing questions broadly. Specific wording for the interviewer is 
denoted in bold font. Follow with the more specific questions.  It is not necessary to explicitly 
ask each of the bulleted prompts within a topic area, but you should refer to the bullets to ensure 
that each topic is addressed with sufficient coverage, rather than focusing on just one or two 
narrow areas. Recall that not all information appearing in  
 
INTERVIEW GUIDE  
 
TO BEGIN:    
11. Introduce yourself and your association with the study. 
12. Explain purpose of the interview. 
13. Thank participants for their willingness to participate. 
14. Assure the participant of confidentiality, including that this study is not related to the 
treatment they will receive at TCC, and that neither the TCC providers nor SDM coach 
will learn their answers. 
15. Let them know the general process of how it will proceed. 
 
 
The purpose of this interview: 
This interview will take approximately 30-45 minutes. I will ask you a variety of questions 
that will help us to better understand your experiences with shared decision making in 
general, how this process goes with your shared decision making coach and prescriber. I 
will ask about your overall impressions, how the timing and length of SDM sessions work, 
how the specific things the SDM coach did or the tools she used impacted you, what does 
and does not work for you in terms of helping you understand your options and 
communicate your decisions to the treatment team. I will also ask how the SDM sessions 
impacted your outcomes in treatment. 
 
How this interview will work:   
I will be asking general questions, and after each one there will be some time for you to 
respond.  We are interested in what you have to say about your experiences, so please 
respond with whatever is on your mind. 
 
I want to remind you that this interview is being recorded. I will try to not use your name 
from the point that I turn on the recorder, and I will ask you to try and not use your name 
or the names of friends or family in any of your responses. This will help keep the interview 
anonymous.   
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I will be using the recording only to remind me of the important things you said so we can 
use your input. The recordings will be transcribed, and then put together with transcripts 
from everyone else taking part in these interviews. All recordings will be deleted after they 
are transcribed. You won’t be able to be individually identified in any of the reports that 
result from these interviews.  
 
Do you have any questions before we start? 
 
INTERVIEW ITEMS 
 
 
XI. FIRST DISCUSSION ITEM  
Purpose: Initial, broad item to get participant to begin thinking about their SDM experiences, 
what it entails, about their role in the process, and the information needed to make it work. 
 
To start, I’d like you to think about shared decision-making when making decisions about 
your psychiatric treatment, what it means and what you think about it. 
 
• How do you understand shared decision making? 
• How do you feel about someone helping you to prepare for visits with your doctor? 
• In general, what do you think of the shared decision making approach? 
• Are there certain decisions where you want input from others before you make 
them? (Some examples) 
• Are there certain decisions that you want a doctor to make? (Some examples)  
• How much responsibility do you want to have in decisions about your mental health 
care? 
• What information do you think is needed from your coach and doctor to help you 
make good decisions? 
• How do you think the information should be presented? 
 
XII. SECOND DISCUSSION ITEM  
Purpose: This item is designed to get participants to begin thinking about their SDM experience 
at TCC specifically, what they thought and felt about it.  
 
Now I’d like you to think about your experiences with the SDM coach at the TCC. 
 
What are some things that you liked or did not like about being in the shared decision 
making meetings with your coach? 
 
You may have experienced different things in SDM or been exposed to different tools 
depending on your needs.  So you may not have experience with many of the things I will 
list. But if you did use them please let me know what you thought about them, positive or 
negative. (Were they helpful, not useful…) 
 
• Specific tools (handouts) 
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• Websites 
• Patient videos 
• TAC-REVIEW process   
XIII. THIRD DISCUSSION ITEM  
Purpose: The purpose of this item is to get the participant discussing any barriers or facilitators 
they saw or experienced in the use of SDM in their clinic. 
At this point I’d like you to think about things that might have made it difficult for you to 
participate in SDM and things that helped to move the process along. (These can be mirror 
images of the questions above and may be unnecessary if they have already discussed.) 
• What kind of problems did you have in participating in SDM? 
• What were the difficulties in understanding shared-decision making? 
• What kind of problems or gaps were there in the information you received from the 
coach or prescriber? 
• What was most helpful about shared decision making? 
• What was least helpful? 
• How did you feel about the length of the sessions? How did you feel about how easy 
or difficult it was to fit the SDM sessions into your visits with your doctor?   
• What kinds of things did your doctor do that may have made it harder for you to 
engage in decisions about your treatment? 
• Were there any other problems in using SDM that we have not yet talked about? 
 
XIV. FOURTH DISCUSSION ITEM    
Purpose: More specific focus on how SDM changed their participation in sessions with the 
prescriber. 
 
Now let’s get a little more focused and talk about how much and in what ways SDM 
changed the way you spoke with your doctor.  (These can be mirror images of the questions 
above and may be unnecessary if they have already discussed.) 
Think of times you met with a doctor before shared decision-making? What differences did 
you find in your treatment? 
• In what ways has your participation in SDM coaching changed the way you work 
with your doctor? 
• In what way did you notice differences in your behavior? 
• In what way did you notice differences in your feelings? 
• In what way did notice differences in how your sessions went compared with other 
medical office visits? 
• In what way did you notice differences in how prepared you thought you were for 
the visit with your doctor? 
• How do you think SDM impacted how seriously your thoughts and concerns were 
taken by the provider?   
• In what way did you feel more or less comfortable voicing your opinion? 
143 
 
• In what way did you feel more or less confident about the choices you made? 
• Did you feel more like an equal partner in your decisions? (Explain) 
 
XV. FIFTH DISCUSSION ITEM    
Purpose: To gather information about how SDM impacted your outcomes  
Think about how SDM impacted your outcomes. 
• In what way did SDM help or hurt your recovery? 
• In what way did SDM help or hurt your chances of continuing mental health 
treatment? 
